Refine
Has Fulltext
- yes (469)
Is part of the Bibliography
- yes (469)
Year of publication
Document Type
- Journal article (239)
- Doctoral Thesis (229)
- Conference Proceeding (1)
Keywords
- Schizophrenie (39)
- schizophrenia (30)
- ADHD (28)
- depression (27)
- Depression (23)
- Serotonin (20)
- fNIRS (14)
- Medizin (12)
- anxiety (12)
- bipolar disorder (12)
- ADHS (11)
- Angststörung (11)
- Aufmerksamkeits-Defizit-Syndrom (11)
- EEG (11)
- Polymorphismus (11)
- fMRI (11)
- hippocampus (10)
- prefrontal cortex (10)
- serotonin (10)
- Angst (9)
- NIR-Spektroskopie (9)
- NIRS (9)
- Präfrontaler Cortex (9)
- genetics (9)
- working memory (9)
- DNA methylation (8)
- Schizophrenia (8)
- panic disorder (8)
- Arbeitsgedächtnis (7)
- BDNF (7)
- Hippocampus (7)
- Neurogenese (7)
- Panikstörung (7)
- ERN (6)
- Genexpression (6)
- Impulsivität (6)
- Kandidatengen (6)
- Leonhard classification (6)
- Leonhard-Klassifikation (6)
- P300 (6)
- Psychiatrie (6)
- Stickstoffmonoxid (6)
- Stickstoffmonoxid-Synthase (6)
- Stress (6)
- Vagus (6)
- epigenetics (6)
- fear conditioning (6)
- gene expression (6)
- mice (6)
- polymorphism (6)
- tDCS (6)
- Alzheimer-Krankheit (5)
- Alzheimer’s disease (5)
- Aufmerksamkeit (5)
- COMT (5)
- COVID-19 (5)
- Dopamin (5)
- EKP (5)
- Elektroencephalogramm (5)
- Ereigniskorreliertes Potenzial (5)
- Furcht (5)
- Karl Leonhard (5)
- Knockout (5)
- Maus (5)
- Quantitative anatomy (5)
- amygdala (5)
- antidepressant (5)
- antidepressants (5)
- anxiety disorders (5)
- brain (5)
- dementia (5)
- dentate gyrus (5)
- dopamine (5)
- gene (5)
- near-infrared spectroscopy (5)
- neuroprotection (5)
- oxidative stress (5)
- psychiatry (5)
- 5-HTTLPR (4)
- Alkoholabhängigkeit (4)
- Alzheimer disease (4)
- Alzheimerkrankheit (4)
- Arzneimittelüberwachung (4)
- Assoziationsstudie (4)
- Bipolar disorder (4)
- Brain-derived neurotrophic factor (4)
- Catecholmethyltransferase <Catechol-0-Methyltransferase> (4)
- ERP (4)
- Emotionsregulation (4)
- Epigenetik (4)
- Funktionelle Kernspintomografie (4)
- Herzfrequenzvariabilität (4)
- Knockout <Molekulargenetik> (4)
- Konditionierung (4)
- Manisch-depressive Krankheit (4)
- Molekulargenetik (4)
- NPY (4)
- Pe (4)
- SNP (4)
- Startle (4)
- adult neurogenesis (4)
- behavior (4)
- candidate gene (4)
- extinction (4)
- genome-wide association (4)
- knockout (4)
- major depression (4)
- mental disorders (4)
- mouse model (4)
- periodic catatonia (4)
- pregnancy (4)
- serotonin transporter (4)
- 5-HT1A (3)
- 5-HT2C (3)
- Albino rats (3)
- Alkoholismus (3)
- Alzheimer (3)
- Alzheimer's disease (3)
- Alzheimers disease (3)
- Amygdala (3)
- Angsterkrankungen (3)
- Angstsensitivität (3)
- Antidepressiva (3)
- Anxiety (3)
- Association study (3)
- Biomarker (3)
- Bipolare Störung (3)
- Cerebellar cortex (3)
- DAT (3)
- Demenz (3)
- Elektroencephalographie (3)
- Emotion (3)
- Ereigniskorrelierte Potentiale (3)
- Extinktion (3)
- FKBP5 (3)
- Genanalyse (3)
- Genetik (3)
- Haplotypanalyse (3)
- ICD-10 (3)
- MDD (3)
- MRI (3)
- Methylphenidat (3)
- Morbus Alzheimer (3)
- NGA (3)
- Paniksyndrom (3)
- Parkinson’s disease (3)
- Persönlichkeit (3)
- Persönlichkeitsstörung (3)
- Pharmakokinetik (3)
- Präfrontaler Kortex (3)
- Purkinje cells (3)
- Serotoninstoffwechsel (3)
- Stathmin (3)
- adulte Neurogenese (3)
- age (3)
- aggression (3)
- association (3)
- attentional bias (3)
- children (3)
- cycloid psychosis (3)
- emotion (3)
- emotional regulation (3)
- executive functions (3)
- fear (3)
- glucocorticoid receptor (3)
- glucose transporter (3)
- humans (3)
- impulsivity (3)
- life events (3)
- major depressive disorder (3)
- mental health (3)
- mild cognitive impairment (3)
- neurodegeneration (3)
- neuroimaging (3)
- neuroinflammation (3)
- neuromelanin (3)
- neuropathology (3)
- polygenic risk score (3)
- psychiatric disorders (3)
- response inhibition (3)
- spider phobia (3)
- stress (3)
- substantia nigra (3)
- therapeutic drug monitoring (3)
- transcranial direct current stimulation (3)
- Ängstliche Depression (3)
- 5-HT transporter (2)
- 5-HT1A receptor (2)
- 5-HTT (2)
- Adult (2)
- Agoraphobie (2)
- Altersdepression (2)
- Antiepileptika (2)
- Antipsychotika (2)
- Antworthemmung (2)
- Approach-Avoidance-Task (2)
- Aufmerksamkeitsdefizit-Syndrom (2)
- Aufmerksamkeitskontrolle (2)
- Aufmerksamkeitslenkung (2)
- Aufmerksamkeitsverzerrung (2)
- Big Five (2)
- CA3 (2)
- CNV (2)
- CPT (2)
- CSF (2)
- Cadherine (2)
- Cerebellum (2)
- Cluster C Persönlichkeitsstörungen (2)
- Coexpression (2)
- Coffin-Lowry syndrome (2)
- Corpus striatum (2)
- Cue-Reaktivität (2)
- Cytokines (2)
- DNA (2)
- DNA methyltransferases (2)
- DNMT3A (2)
- Duplikation (2)
- EDA (2)
- Elektrophysiologie (2)
- Emotional processing (2)
- Erwachsener (2)
- Escitalopram (2)
- Expositionstherapie (2)
- FAAH (2)
- FMRI (2)
- Fehlerverarbeitung (2)
- Fibromyalgia syndrome (2)
- Frühdiagnostik (2)
- Furchtkonditionierung (2)
- GABA (2)
- GLUT3 (2)
- Gehirn (2)
- Gen (2)
- Genmutation (2)
- HPA axis (2)
- Haplotyp (2)
- Hautleitfähigkeit (2)
- IAPS (2)
- Inflammation (2)
- Inhibition (2)
- Insulin (2)
- Katatonie (2)
- Ki-67 (2)
- Klassifikation der endogenen Psychosen (2)
- Kognition (2)
- Konflikterkennung (2)
- LORETA (2)
- Lebensqualität (2)
- Leichte kognitive Beeinträchtigung (2)
- Lipofuscin (2)
- MEG (2)
- MLC1 (2)
- Mice (2)
- Migräne (2)
- Monoaminoxidase (2)
- NOS1AP (2)
- NPSR1 (2)
- Nah-Infrarot-Spektroskopie (2)
- Neuroendokrines System (2)
- Neurotransmitter (2)
- OCD (2)
- P50 (2)
- PARK2 (2)
- PFC (2)
- Parkinson disease (2)
- Parkinson's disease (2)
- Parkinson-Krankheit (2)
- Persönlichkeitsmerkmale (2)
- Pharmakotherapie (2)
- Phobie (2)
- Polymerase-Kettenreaktion (2)
- Prefrontal cortex (2)
- Promotor (2)
- Promotorpolymorphismus (2)
- Prävention (2)
- Psychiatric disorders (2)
- Psychopathologie (2)
- Psychopharmaka (2)
- Psychopharmakon (2)
- Q-T-Verlängerung (2)
- Qualitätssicherung (2)
- RSK2 (2)
- Rauchen (2)
- Rehabilitation (2)
- SERT (2)
- SLC12A6 (2)
- SLC2A3 (2)
- Schreckreaktion (2)
- Schwangerschaft (2)
- Senile Demenz (2)
- Serotonin transporter (2)
- Serotonin-Transporter (2)
- Serotonintransporter (2)
- Serumkonzentration (2)
- Somatosensorisch evoziertes Potenzial (2)
- Stereology (2)
- Stickstoffoxidsynthase (2)
- Stressreaktion (2)
- Thalamus (2)
- Therapeutisches Drug Monitoring (2)
- Tiermodell (2)
- Tryptophan hydroxylase 2 (2)
- VFT (2)
- Vasopressin (2)
- Venlafaxin (2)
- Working memory (2)
- action monitoring (2)
- activation (2)
- active zone (2)
- adult ADHD (2)
- adversity (2)
- affective disorders (2)
- affektive Störungen (2)
- aging (2)
- alliance (2)
- alpha-synuclein (2)
- animal behavior (2)
- anterior cingulate cortex (2)
- anterior insula (2)
- association study (2)
- astrocytes (2)
- attentional control (2)
- behaviour (2)
- biomarker (2)
- biomarkers (2)
- bipolar affective disorder (2)
- cerebellum (2)
- chronic heart failure (2)
- classification of endogenous psychosis (2)
- cognitive control (2)
- cognitive decline (2)
- cognitive impairment (2)
- coping (2)
- cortical activation (2)
- cue-reactivity (2)
- cycloid psychoses (2)
- depressive disorder (2)
- disease progression (2)
- disorder (2)
- dorsolateral prefrontal cortex (2)
- early recognition (2)
- early-life stress (2)
- efficacy (2)
- electroencephalography (2)
- emotion regulation (2)
- endocannabinoid (2)
- endophenotype (2)
- error-related negativity (2)
- event-related potentials (2)
- evoked potentials (2)
- evozierte Potentiale (2)
- expression (2)
- fear generalization (2)
- fear-potentiated startle (2)
- fibromyalgia (2)
- frontotemporal dementia (2)
- functional magnetic resonance imaging (2)
- functional near-infrared spectroscopy (2)
- functional neuroimaging (2)
- glutamate (2)
- hiPSC (2)
- illness (2)
- immediate early genes (2)
- inflammation (2)
- insulin receptor (2)
- iron (2)
- knockout mice (2)
- lactation (2)
- learning (2)
- lithium (2)
- long-term potentiation (2)
- longitudinal studies (2)
- migraine (2)
- monoamine oxidase (2)
- mouse (2)
- mutation (2)
- myelination (2)
- myocardial infarction (2)
- negative affect (2)
- neurodevelopment (2)
- neurogenesis (2)
- neuropsychiatric disorders (2)
- neuropsychology (2)
- nitric oxide synthase (2)
- obesity (2)
- oligodendrocyte (2)
- pain (2)
- parietal hypoactivation (2)
- peripartum (2)
- personality (2)
- personality disorder (2)
- pharmacovigilance (2)
- plasticity (2)
- polymorphisms (2)
- potassium chloride co-transporter 3 (2)
- prediction (2)
- prefrontal activity (2)
- prenatal stress (2)
- promoter polymorphism (2)
- proteomics (2)
- präfrontaler Kortex (2)
- psychopathology (2)
- psychosocial stress (2)
- quality of life (2)
- rat (2)
- reaction time (2)
- regulatory T cells (2)
- reliability (2)
- sensitivity (2)
- serotonin deficiency (2)
- serotonin transporter gene (2)
- serum concentration (2)
- smoking (2)
- social decision-making (2)
- social interaction (2)
- startle reflex (2)
- streptozotocin (2)
- substantia nigra pars compacta (2)
- suicide prevention (2)
- sustained fear (2)
- systematic review (2)
- target (2)
- temporoparietal junction (2)
- transkranielle Gleichstromstimulation (2)
- triple in situ hybridization (2)
- tryptophan (2)
- zykloide Psychose (2)
- "Familiär-sporadisch"- Konzept (1)
- 123I-mIBG (1)
- 1p13.3 (1)
- 1q21 (1)
- 3D reconstruction (1)
- 3D-Rekonstruktion (1)
- 5-HT (1)
- 5-HT1A-Polymorphismus (1)
- 5-HT1A-polymorphism (1)
- 5-HT2A (1)
- 5-HT3A (1)
- 5-HTT knockout mice (1)
- 5-HTT polymorphism (1)
- 5-HTT-Polymorphismus (1)
- 5HT1A (1)
- 5HTT (1)
- 5HTTLPR (1)
- 7q11.2 (1)
- AAT (1)
- ACC (1)
- ACE-Hemmer (1)
- ACE-inhibitor (1)
- ADORA2A (1)
- ASIC1 (1)
- AT1-Rezeptor-Antagonist (1)
- Abelson helper integration-1 (AHI1) (1)
- Abstinenz (1)
- Activation (1)
- Acute tryptophan depletion (1)
- Adaptation (1)
- Adenosin (1)
- Adipositas (1)
- Adult head (1)
- Adulte Neurogenese (1)
- Adults (1)
- Affective psychoses (1)
- Ageing (1)
- Aggression (1)
- Aggressive behaviour (1)
- Akustischer Startle Reflex (1)
- Albino rat (1)
- Albinoratten (1)
- Algorithmus (1)
- Alkohol-Craving tDCS (1)
- Alkoholabhängikeit (1)
- Alkoholkonsum (1)
- Alkoholmissbrauch (1)
- Altersmedizin (1)
- Alterspsychiatrie (1)
- Alzheimer's Dementia (1)
- Alzheimer´s disease (1)
- Alzheimer’s dementia (1)
- Ammonshorn (1)
- Angst als Zustand (1)
- Angsterkrankung (1)
- Angstreaktionen (1)
- Angstsensitivitätsindex-3 (1)
- Angstsyndrom (1)
- Angstverarbeitung (1)
- Animal behavior IntelliCage system (1)
- Animal model (1)
- Animales Nervensystem (1)
- Ankyrin (1)
- Anorexia nervosa (1)
- Anteriorer cingulärer Cortex (1)
- Anteriores Cingulum (1)
- Anti-Suizid-Vertrag (1)
- Antidepressants (1)
- Antidepressivum (1)
- Antikonvulsiva (1)
- Antipsychotics (1)
- Antizipation (1)
- Anxiety Disorders (1)
- Anxiety Sensetivity Index (1)
- Anxiety disorder (1)
- Anxiety disorders (1)
- Anxiety sensitivity (1)
- Anxiety-like behavior (1)
- ApoE-Genotyp (1)
- Apolipoprotein (1)
- Apolipoprotein E (1)
- Arbeitsg (1)
- Arzneimittelinteraktion (1)
- Association analyses (1)
- Associative learning (1)
- Assoziation (1)
- Assoziationsanalyse (1)
- Assoziationsstudien (1)
- Assoziationsuntersuchung (1)
- Assoziatives Lernen (1)
- Astrozyten (1)
- Attention Deficit Hyperactivity Disorder (ADHD) (1)
- Attention Switching (1)
- Attention-deficit/hyperactivity disorder (1)
- Atypische Antipsychotika (1)
- Auditory pathway (1)
- Auditory targets (1)
- Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (1)
- Aurikuläre Vagusnervstimulation (1)
- Autismus (1)
- Automatische Annäherungstendenzen (1)
- Automatische Klassifikation (1)
- Autoradiographie (1)
- Autoradiography (1)
- Axonal degeneration (1)
- B 37 CAG repeat locus (1)
- BDNF Astrozyten depressive Episode (1)
- BDNF Val66Met (1)
- BIS (1)
- Balints-Syndrome (1)
- Ballerspiel (1)
- Basalganglien (1)
- Bed nucleus of stria terminalis (1)
- Beer-lambert law (1)
- Befindlichkeit (1)
- Belegung (1)
- Beruf (1)
- Berufsklassifikation (1)
- Bestärkendes Lernen <Künstliche Intelligenz> (1)
- Bias (1)
- Bildgebendes Verfahren (1)
- Biomarke (1)
- Biomarkers (1)
- Bipolar DGKH-GAT Endophänotypen (1)
- Bipolar-affektive Störung (1)
- Bipolare affektive Störung (1)
- Blood-brain barrier (1)
- Blutgerinnung (1)
- Body weight (1)
- Borderline-Persönlichkeitsstörung (1)
- Brain (1)
- Brain atrophy (1)
- Brain mappins (1)
- Brain trauma (1)
- Bromdesoxyuridin <5-Brom-2-desoxyuridin> (1)
- Bulimia nervosa (1)
- C(-1019)G polymorphism (1)
- C-reactive protein (1)
- C-reaktives Protein (1)
- CA4 (1)
- CAPS (1)
- CDH13 (1)
- CDH13 Expression (1)
- CDH13 mRNA (1)
- CERK1 (1)
- CLN3 (1)
- CNS (1)
- CNVs (1)
- COGITAT-Box (1)
- COMT VAL(158)MET polymorphism (1)
- COMT Val 158Met Polymorphism (1)
- COMT-Polymorphismus (1)
- COMT-Val158Met (1)
- CREB (1)
- CRH1 (1)
- CRHR (1)
- CRISPR-Cas Systems (1)
- CRP (1)
- Cadherin (CDH13) (1)
- Cadherin-13 (CDH13) (1)
- Capillaries (1)
- Carbamazepin (1)
- Case-Control Studies (1)
- Catechol-0-Methyltransferase (1)
- Catecholmethyltransferase (1)
- Caudate nucleus (1)
- Cdh13 (1)
- Cerebellar nuclei (1)
- Cerebrolysin (1)
- Cerebrospinal fluid (1)
- Charakterisierung (1)
- Chemische Synthese (1)
- Cholinerges System (1)
- Chromosom 22q11 (1)
- Chronic disease (1)
- Chronic heart failure (1)
- Chronic stress (1)
- Chronische Depression (1)
- Chronische Schizophrenie (1)
- Citalopram (1)
- Claustrum (1)
- Clinical Genetics (1)
- Cluster C personality disorder (1)
- Cluster C personality disorders (1)
- Cognitive Therapy (1)
- Cognitive control (1)
- Cognitive decline (1)
- Comorbidity (1)
- Corpus amygdaloideum (1)
- Covid-19 (1)
- Craving (1)
- Cues (1)
- D-Aminosäure-Oxidase (1)
- D-amino acid oxidase activator (1)
- D-amino-acid-oxidase (1)
- DAOA (1)
- DLPFC (1)
- DNA Methylation (1)
- DNA damage (1)
- DNA-Methylierung (1)
- DNA-Methyltransferasen (1)
- DNMT3B (1)
- DRD2 (1)
- DRD2-Rezeptor-Gen (1)
- DRD4 (1)
- DSM-IV (1)
- DSM-IV-TR (1)
- DYNLL1 (1)
- De-novo (1)
- Delay Aversion (1)
- Delay Discounting (1)
- Deletion <Genetik> (1)
- Dementia (1)
- Demenz vom Alzheimer Typ (1)
- Demyelination (1)
- Demyelinisierung (1)
- Dental Phobia (1)
- Dentalphobie (1)
- Diabetes Mellitus Typ 2 (1)
- Diabetes mellitus (1)
- Diabetic polyneuropathy (1)
- Diagnostic (1)
- Differentielle Genexpression (1)
- Dimension 3 (1)
- Disease progression (1)
- Disease-modifying therapies (1)
- Diskriminanzanalyse (1)
- Disorders (1)
- Dissoziale Persönlichkeitsstörung (1)
- Distress (1)
- Diuretikum (1)
- Dopamin-beta-Hydroxylase (1)
- Dopamine (1)
- Dopamine Transporter (1)
- Dopamine melanin (1)
- Dopaminrezeptor (1)
- Dopaminstoffwechsel (1)
- Dopamintransporter (1)
- Dorsolateral prefrontal cortex (1)
- Dreidimensionale Rekonstruktion (1)
- Drosophila (1)
- Drosophila model (1)
- Drug development (1)
- Duloxetin (1)
- Dynamic Causal Modeling (1)
- Dysbindin (1)
- E3 ubiquitin ligase (1)
- EBM (1)
- EMG (1)
- EPN (1)
- ERN/Ne (1)
- Early Posterior Negativity (1)
- Early infant catatonia (1)
- Early-onset (1)
- Ecological Momentary Assessment (1)
- Ego-Shooter (1)
- Ehescheidung (1)
- Einfühlung <Motiv> (1)
- Einsamkeit (1)
- Elektrotherapie (1)
- Elevated Plus Maze (1)
- Emotionen (1)
- Emotionsverarbeitung (1)
- Endophänotyp (1)
- Enrichment analysis (1)
- Entgiftung (1)
- Entlassungsmanagement (1)
- Entscheidungsprozess (1)
- Entwicklung (1)
- Entzug (1)
- Entzündung (1)
- Entzündungsparameter (1)
- Entzündungsparametern (1)
- Enzym (1)
- EphA4 (1)
- Epigenesis (1)
- Epigenetic (1)
- Ereigniskorrelierte Potentiale EKP (1)
- Eriksen Flanker Task (1)
- Eriksen flanker task (1)
- Eriksen-Flanker-Test (1)
- Erwachsene (1)
- Erwachsenenalter (1)
- Essstörungen (1)
- Europe (1)
- Event related potentials (1)
- Event-related potentials (1)
- Evoked potential (1)
- Evoziertes Potenzial (1)
- Excitatory/inhibitory imbalance (1)
- Exposition (1)
- Expositionsbehandlung (1)
- Expositionslernen (1)
- Exposure treatment (1)
- Expression (1)
- Extraversion (1)
- FEV gene (1)
- FNIRS (1)
- FPI-R (1)
- Familial/sporadic concept (1)
- Fear (1)
- Fear Conditioning (1)
- Fear Extinction (1)
- Fehlerbeobachtung (1)
- Fehlererkennung (1)
- Fehlermonitoring (1)
- Fehlermonitoring (ERN) (1)
- Female (1)
- Flupentixol (1)
- Frühkindliche Katatonie (1)
- Frühkindlicher Hirnschaden (1)
- Functional Connectivity (1)
- Funktionelle Bildgebung (1)
- Funktionelle Kernspintomographie (1)
- Funktionelle Konnektivität (1)
- Furchtgeneralisierung (1)
- Fzd3 (1)
- G-protein inwardly rectifying potassium channel (1)
- G72 (1)
- GABBR1 (1)
- GAD1 (1)
- GAP (1)
- GFAP (1)
- GHQ-28 (1)
- GIRK 2 (1)
- GLRB (1)
- GPCRs (1)
- GRN (1)
- GWAS (1)
- Gauss Prozess Klassifikation (1)
- Gaussian Process Classification (1)
- Geistige Behinderung (1)
- Geistlicher Beruf (1)
- Gelelektrophorese (1)
- Gemeindepsychiatrie (1)
- Gen Polymorphismen (1)
- Gen Umweltinteraktion (1)
- Gen-Umwelt-Interaktion (1)
- Gen-Umwelt-Interaktionen (1)
- Gene by Environment (1)
- Genemutation (1)
- Generic questionnaire (1)
- Genetic (1)
- Genklonierung (1)
- Genomische Bildgebung (1)
- Genotype (1)
- Geriatrie (1)
- Gerontopsychiatrie (1)
- Geschlechtsunterschiede (1)
- Gewalt (1)
- Gewalttätigkeit (1)
- Gewicht (1)
- Glial fibrillary acidic protein (1)
- Gliogenese (1)
- Glucocorticosteroidrezeptor (1)
- Glucose (1)
- Glucosestoffwechsel (1)
- Glucosetransporter (1)
- Glutamat (1)
- Granular layer (1)
- Gray, Jeffrey Alan (1)
- Gyrus dentatus (1)
- HAND (1)
- HDBSCAN (1)
- HIV (1)
- HIV-Demenz (1)
- HIV-dementia (1)
- HRV (1)
- Habituationstraining (1)
- Handlung (1)
- Handlungsüberwachung (1)
- Haplotype (1)
- Heilberuf (1)
- Helfender Beruf (1)
- Hemmung (1)
- Herzfrequenz (1)
- Hirninfarkt (1)
- Hirnstimulation (1)
- Histochemie (1)
- Htr1a (1)
- Htr2a (1)
- Htr2c (1)
- Human CDH13 (1)
- Human behaviour (1)
- Human brain (1)
- Human entorhinal area (1)
- Humans (1)
- Huntington's disease . Human cerebral cortex (1)
- Hurst Exponent (1)
- Hyperintense Marklagerläsionen (1)
- Hyperintense white matter lesions (1)
- Hypertonie (1)
- Hypofrontalität (1)
- Hyponatriämie (1)
- Hämodialyse (1)
- I7 (1)
- ICT (1)
- IDCL-P (1)
- IMpACT (1)
- Iife threatening catatonic syndrome (1)
- Ile408Val-Polymorphismus (1)
- Imaging genomics (1)
- Imipramin (1)
- Immonology (1)
- Immunhistochemie (1)
- Immunologie (1)
- Immunparameter (1)
- Implizites Gedächtnis (1)
- Inanspruchnahme (1)
- Induced Pluripotent Stem Cells (1)
- Induzierte pluripotente Stammzelle (1)
- Inflammatio (1)
- Informationsverarbeitung (1)
- Insensitivity (1)
- Insulin Degrading Enzyme (1)
- Insulin resistance (1)
- Interaktion (1)
- Interaktionen (1)
- Interferon-alpha (1)
- Internationale Wernicke-Kleist-Leonhard-Gesellschaft (1)
- Interneuron (1)
- Japanese population (1)
- Jugendamt (1)
- Jurist (1)
- KCC3 (1)
- KCNJ6 (1)
- KCNN3 (1)
- KFZA (1)
- KIAA0027 (1)
- KIAA1646 (1)
- Kalium-Chlorid-Cotransporter 3 (1)
- Kaliumkanal (1)
- Kandidatengene (1)
- Kataphasie (1)
- Kernspintomografie (1)
- Kinder (1)
- Kindesmisshandlung (1)
- Klassifikations- und Regressionsbaum (1)
- Klinische Psychiatrie (1)
- Klonierung (1)
- Knock-out mice (1)
- Knockout-Maus (1)
- Koffein (1)
- Kognitive Kontrolle (1)
- Komorbidität (1)
- Konfliktverarbeitung (1)
- Kontusion (1)
- Konzentration (1)
- Kopienzahlvariation (1)
- Kopplungsanalyse (1)
- Kortikale Regulation (1)
- Kriminalität (1)
- Kulturberuf (1)
- Körpertherapie (1)
- Körperwahrnehmung (1)
- LPHN3 (1)
- LPS (1)
- Lamotrigin (1)
- Late Positive Potential (1)
- Latency (1)
- Lateralitity (1)
- Laterality (1)
- Lebendnierenspende (1)
- Lebendnierentransplantation (1)
- Lebensereignisse (1)
- Leo (1)
- Leonhard Klassifikation (1)
- Leonhard cIassification (1)
- Leonhard´s classification (1)
- Lernstrategien (1)
- Lernstrategien bei Geschlecht Fach Semester (1)
- Leuk (1)
- Leukoaraiose (1)
- Leukoaraiosis (1)
- Leukozyten (1)
- Liquor (1)
- Lithium (1)
- Locus coeruleus (1)
- Long-term depression (1)
- MAOA (1)
- MAPK signaling (1)
- MCPH1 (1)
- MIBG (1)
- MNS (1)
- MPH (1)
- MRT (1)
- Magnetische Resonanz (1)
- Maintenance treatment (1)
- Major depression (1)
- Malignant neuroleptic syndrome (1)
- Malignes neuroleptisches Syndrom (1)
- Mandelkernkomplex (1)
- Mania (1)
- Manie (1)
- Massage (1)
- Massagetherapie (1)
- Maternal infections (1)
- Measurement invariance (1)
- Media (1)
- Medicine (1)
- Memory dysfunction (1)
- Mensch (1)
- Messenger-RNA (1)
- Metaiodobenzylguanidine (1)
- Methylierung (1)
- MiMIC (1)
- Migraine (1)
- Migrationshintergrund (1)
- Mikrokernfrequenzanalyse (1)
- Mirror neuron system (1)
- Mismatch Negativity MMN (1)
- Mlc1 (1)
- Model (1)
- Modellierung (1)
- Moderator (1)
- Molecular biology (1)
- Molecular-genetics (1)
- Monoamine (1)
- Monoamine Oxidase/genetics (1)
- Monopolar depression (1)
- Mood disorders (1)
- Motor nerve biopsy (1)
- Motorischer Cortex (1)
- Motorisches System (1)
- Mouse-brain (1)
- Multimorbidität (1)
- Mutationsanalyse (1)
- Münchhausen by proxy (1)
- Münchhausen-Syndrom der Angehörigen (1)
- Mütter (1)
- N-Back-Test (1)
- N170 (1)
- N200 (1)
- NADPH-Dehydrogenase (1)
- NADPHd (1)
- NCAM1 (1)
- NEO PI-R (1)
- NMDA-Rezeptor (1)
- NMR-Tomographie (1)
- NO (1)
- NO-Synthetase (1)
- NOS (1)
- NOS-I knockout mice (1)
- NOS-I-Knockout-Mäuse (1)
- NOS1 (1)
- NOS1 ex1f-VNTR Polymorphismus (1)
- NOS1VNTR (1)
- NPU (1)
- NR3C1 (1)
- NSAID (1)
- Nah-Infrarot Reflexionsspektroskopie (1)
- Nahinfrarotspektroskopie (1)
- Nebenwirkung (1)
- Negative difference Nd (1)
- Neostriatum (1)
- Nerve fibers (1)
- Nesplora Aquarium (1)
- Neurobiologie (1)
- Neurodegeneration (1)
- Neurodevelopmental Disorder (1)
- Neurogenetik (1)
- Neuroimaging (1)
- Neuroinflammation (1)
- Neuroleptika (1)
- Neurologie (1)
- Neurolucida (1)
- Neuromelanin (1)
- Neuromorphologie (1)
- Neuronal plasticity (1)
- Neurone number (1)
- Neurons (1)
- Neuropathy (1)
- Neuropeptid S Rezeptor Gen (1)
- Neuropeptid Y (1)
- Neuropeptide Y (1)
- Neuroplasticity (1)
- Neuroprotection (1)
- Neuropsychiatrie (1)
- Neuropsychologie (1)
- Neurotrophic factors (1)
- Neurotrophine (1)
- Neurowissenschaften (1)
- Nicht-Suizid-Vertrag (1)
- Niereninsuffizienz (1)
- Nissl stain (1)
- Nitric oxide (1)
- Nitric oxide synthase (1)
- NoGo-P300 (1)
- Npy (1)
- Npyr1 (1)
- Npyr2 (1)
- Nucleus accumbens (1)
- Ontogeny (1)
- Operante Konditionierung (1)
- Opioid receptor (1)
- Oppositionelle Störung (1)
- Orexin (1)
- Orexin-/Hypocretin- Rezeptor-1 (HCRTR1)-Gen (1)
- Orexin-System (1)
- Oxidative Stress (1)
- Oxidativer Stress (1)
- Oxytocin (1)
- P100 (1)
- P150 (1)
- P300 topography (1)
- PAX genes (1)
- PAX-7 (1)
- PAX-Gene (1)
- PET-1 (1)
- PLC (1)
- PTSD (1)
- PYY3-36 (1)
- Paarbindungsverhalten (1)
- Panic Disorder/genetics (1)
- Panic Disorder/therapy (1)
- Panikerkrankung (1)
- Pannexin (1)
- Parallel fiber synapses (1)
- Paranoide Schizophrenie (1)
- Paraphrenie <Schizophrenie> (1)
- Parkinson (1)
- Parkinsonism (1)
- Pathogenese (1)
- Patienten (1)
- Patientenklassifikation (1)
- Perinatal Asphyxia (1)
- Perinatal brain damage (1)
- Periodische Katatonie (1)
- Peristenz (1)
- Periventricular hyperintensities (1)
- Periventrikuläre Hyperintensitäten (1)
- Personalized medicine (1)
- Persönlichkeitsstörungen (1)
- Persönlichkeitstheorie (1)
- Persönlichkeitsveränderung (1)
- Pharmakoepigenetik (1)
- Pharmakogenetik (1)
- Pharmakovigilanz (1)
- Phasic Fear (1)
- Photon migration (1)
- Physikalische Therapie (1)
- Physiological functions (1)
- Phänotypen (1)
- Pigmentarchitectonics (1)
- Plasma Level (1)
- Polarity index (1)
- Polygener Risikoscore (1)
- Polymo (1)
- Polymorphismen (1)
- Polytoxikomanie (1)
- Poststroke depression (1)
- Predominant polarity (1)
- Prefrontalt Cortex (1)
- Pregnancy (1)
- Prevention (1)
- Primaten (1)
- Primärprävention (1)
- Prognostic markers (1)
- Progranulin (1)
- Promotor <Genetik> (1)
- Propagation (1)
- Prosaccade (1)
- Prosoziales Verhalten (1)
- Prädiabetes (1)
- Prädiktor (1)
- Prädiktoren (1)
- Präfrontaler Kortex (PFC) (1)
- Prävention Prüfungsangst (1)
- Prüfungsangst (1)
- Psychiatrische Versorgung (1)
- Psychisch Kranker (1)
- Psychische Störung (1)
- Psychogalvanische Reaktion (1)
- Psychologie (1)
- Psychoneuroimmunologie (1)
- Psychopathology (1)
- Psychopharmakatherapie (1)
- Psychopharmakotherapie (1)
- Psychotherapie (1)
- Punktmutation (1)
- Purkinje-Zellen (1)
- Putamen (1)
- Pyramidenzelle (1)
- Pädagogischer Beruf (1)
- QE (1)
- QT-Verlängerung (1)
- QT-prolongation (1)
- QTc prolongation (1)
- QTc-Verlängerung (1)
- QTc-Zeit (1)
- QTc-Zeit Verlängerung (1)
- Qb-Test (1)
- Quantitative Anatomie (1)
- Querschnittsanalyse (1)
- Quetiapin (1)
- Quetiapine (1)
- RFLP (1)
- RIM1α (1)
- RNA Sequencing (1)
- RNA expression (1)
- RSK (1)
- RTMS (1)
- Raphe (1)
- Rat-brain (1)
- Regional differences (1)
- Regulator of G protein signaling 2 (1)
- Rehaklinik (1)
- Reliabilität (1)
- Reproduzierbarkeit (1)
- Resilienz (1)
- Resting-EEG (1)
- Restraint stress (1)
- Rezeptor (1)
- Rgs2 (1)
- Risikofaktor (1)
- Risikofaktoren (1)
- Riskanter Alkoholkonsum (1)
- Rotary EXcitation (REX) (1)
- Roux-en-Y gastric bypass surgery (1)
- Ruhe-EEG (1)
- Ruhebedingungen (1)
- S-HT (1)
- S6KII RSK (1)
- SARS-CoV-2 (1)
- SARS-CoV-2 brain disorders (1)
- SAT (1)
- SCF (1)
- SHANK3 (1)
- SIV (1)
- SKP1 (1)
- SLC6A4 (1)
- SMARCA2 (1)
- SNAP-25 (1)
- SNRI (1)
- SPAN (1)
- SSRI (1)
- STORM (1)
- SV pool (1)
- SV2C ADHD (1)
- SV2C ADHS (1)
- Saccadic eye-movements (1)
- Scattering (1)
- Schizoaffektive Psychose (1)
- Schizophrenieerkrankung (1)
- Schreckreflex (1)
- Schwangerschaftsinfektion (1)
- Secondary affective disorder (1)
- Sekundärkrankheit (1)
- Selbstmord (1)
- Selbstwirksamkeit (1)
- Selective attention (1)
- Senescent rat (1)
- Senile rat (1)
- Senile rats (1)
- Sensory Gating (1)
- Sequence Analysis (1)
- Serotonerges System (1)
- Serotonin transporter polymorphism (1)
- Serotonin-Reuptake-Hemmer (1)
- Serotonin-Transporter-Gen (1)
- Serotonin-Transporter-Polymorphism (1)
- Serotonine transporter (1)
- Serotoninrezeptor (1)
- Sert-deficient mice (1)
- Sertralin (1)
- Serum (1)
- Set Shifting (1)
- Setshifting (1)
- Sexualität (1)
- Siekiera (1)
- Skin biopsy (1)
- Skin conductance (1)
- Small RNA (1)
- Social Buffering (1)
- Social Distancing (1)
- Social buffering (1)
- Social interaction (1)
- Somatosensibel evozierte Potentiale des N. vagus (1)
- Somatosensibel evozierte Potenziale des Nervus vagus (1)
- Somatosensibel-evozierte Potentiale des N. Vagus (1)
- Somatosensory evoked potentials of N. vagus (1)
- Sonic hedgehog (1)
- Sozial evaluative Situation (1)
- Sozialberuf (1)
- Sozialdienst (1)
- Soziale Arbeit (1)
- Soziale Interaktion (1)
- Sozialer Kontakt (1)
- Sozialer Stress (1)
- Specific Phobia (1)
- Spectroscopy fnirs (1)
- Spezifische Phobien (1)
- Spiegelneuron (1)
- Spiegelneuronensystem (1)
- Spinal nerves (1)
- Spines (1)
- Spinnenphobie (1)
- Spontan Hypertensive Ratte (1)
- Stationäre psychiatrische Versorgung (1)
- Stereotaxie (1)
- Stereotaxy (1)
- Stimmungsstabilisator (1)
- Stimuli (1)
- Stoppsignal (1)
- Strain differences (1)
- Striatum (1)
- Stroop (1)
- Studienerfolg und Prüfungsangst (1)
- Störung (1)
- Störung des Sozialverhaltens (1)
- Sub-saharan Africa (1)
- Sucht (1)
- Suchtreize (1)
- Suchtreizreaktivität (1)
- Sugar (1)
- Suizid (1)
- Suizidalität (1)
- Suizidversuch (1)
- Superoxiddismutase (1)
- Superoxide dismutase (1)
- Surrogate endpoints (1)
- Sustained Fear (1)
- System (1)
- Systematic review (1)
- Systematik (1)
- Systematische Paraphrenie (1)
- T-cadherin (1)
- TDM (1)
- TMS (1)
- TPH (1)
- TPH2 gene (1)
- TPQ (1)
- Task-performance (1)
- Temporal predictability (1)
- Testgütekriterium (1)
- Thalamic nuclei (1)
- Therapeutic Drug Monitoring (1)
- Therapeutic drug monitoring (1)
- Therapeutisches Drug monitoring (1)
- Therapie (1)
- Theta Burst Stimulation (1)
- Thrombozyt (1)
- Tinnitus (1)
- Tissues (1)
- Toll-like receptor 4 (TLR4) (1)
- Trailmaking Test (1)
- Transcranial Magnetic Stimulation (1)
- Transgenic mice (1)
- Transkranielle Magnetstimulation (1)
- Transkranielle Magnetstimulation (TMS) (1)
- Transkriptionsfaktor (1)
- Transkutane Vagusnervstimulation (1)
- Transkutane elektrische Nervenstimulation (1)
- Transporter (1)
- Trauma (1)
- Trennungsangst (1)
- Triple in situ hybridization (1)
- Tryptophan hydroxylase-2 (Tph2) (1)
- Tryptophanhydroxylase 2 (1)
- UPPS (1)
- Ultrastructure (1)
- Unc-13 (1)
- VAL66MET polymorphism (1)
- VBM (1)
- VITA Studie (1)
- VITA study (1)
- VSEP (1)
- Vagus-somatosensorisch evozierte Potentiale (1)
- Vagusevozierte Potentiale (1)
- Val158Met-COMT-Polymorphismus (1)
- Valproat (1)
- Valproinsäure (1)
- Vasopressin receptor gene (1)
- Vasopressinrezeptorgen (1)
- Verbal Flue (1)
- Vergence (1)
- Verhalten (1)
- Vigilanz (1)
- Vitamin D (1)
- Vitamin-D-Mangel (1)
- Voluntary control (1)
- Vorhersagbarkeit (1)
- WURS (1)
- Warburg-Effect (1)
- Western diet (1)
- Wirkmechanismus (1)
- Wortflüssigkeitstest (1)
- Würzburg / Institut für Humangenetik (1)
- Würzburger Adipositas Studie (1)
- Xenopus laevis oocytes (1)
- Zahnbehandlungsphobie (1)
- Zellkultur (1)
- Zerebraler Insulinmetabolismus (1)
- Zusammenhang Lernstrategien (1)
- Zuweisung (1)
- Zwangsstörung (1)
- Zykloide Psychose (1)
- aVNS (1)
- abstinence (1)
- accidents (1)
- acetylcholine (1)
- acid sphingomyelinase (1)
- acoustic startle (1)
- acoustic startle reflex (1)
- acute brain slices (1)
- acute mania (1)
- acute stress (1)
- adenosine (1)
- adolescence (1)
- adult Neurogenesis (1)
- adult attention deficit/hyperactivity disorder (1)
- adult attention deficit/hyperactivity disorder (adult ADHD) (1)
- adult treatment (1)
- adulte ADHS (1)
- adulte neurogenese (1)
- adultes ADHS (1)
- adulthood (1)
- adults (1)
- adverse drug reactions (1)
- advisory groups (1)
- affect-laden paraphrenia (1)
- affective state (1)
- affektvolle Paraphrenie (1)
- age stereotypes (1)
- aggressiveness (1)
- aging and cell death (1)
- aging brain (1)
- aging-related disease (1)
- agoraphobia (1)
- agreeableness (1)
- akustisch evozierte Potentiale (1)
- akut lebensbedrohlich katatones Syndrom (1)
- alcohol addiction (1)
- alcohol dependance (1)
- alcohol dependency (1)
- alcoholism (1)
- allocation (1)
- allostatic load (1)
- ambulante psychotherapeutische Versorgung (1)
- amino acid analysis (1)
- amitriptyline (1)
- amygdala response (1)
- analysis of variance (1)
- animal performance (1)
- anti-depressive treatment (1)
- anti-suicide-contract (1)
- anticipation (1)
- anticipatory anxiety (1)
- antidepressant drug (1)
- antidepressive Therapie (1)
- antidepressive agents (1)
- antipsychotics (1)
- anxiety like (1)
- anxiety-like behavior (1)
- aphasia (1)
- apolipoprotein (1)
- apolipoprotein-E4 (1)
- apoptosis (1)
- appetitive Reaktionstendenzen (1)
- assay (1)
- assessment of cognitive disorders/dementia (1)
- association studies (1)
- atlas‐based volumetry (1)
- atopic dermatitis (1)
- attention (1)
- attention deficit hyperactivity disorder (1)
- attention deficit/hyperactivity disorder (1)
- attention-deficit/hyperactivity disorder (ADHD) (1)
- attentional blink (1)
- atypical antipsychotic (1)
- auditory cortex (1)
- auditory evoked potentials (1)
- auricular vagusnervstimulation (1)
- aurikuläre Vagusnervstimulation (1)
- autism (1)
- autism spectrum disorder (1)
- autism-like behavior (1)
- autoinhibition (1)
- awareness (1)
- axonal transport (1)
- basal ganglia (1)
- bdnf (1)
- behavioral activation system (1)
- beside test (1)
- biased signaling (1)
- bipolar (1)
- bipolar affektive Erkrankung (1)
- bipolar disorders (1)
- bipolar-affektive Erkrankung (1)
- bipolare (1)
- bipolare Erkrankung (1)
- bipolare Störung (1)
- bleeding (1)
- blood biomarker (1)
- body awareness (1)
- bold (1)
- bold activity (1)
- brain activation (1)
- brain bank (1)
- brain derived neurotrophic factor (1)
- brain development (1)
- brain disorders (1)
- brain insulin system (1)
- brain pathology (1)
- brain stem (1)
- brain stimulation (1)
- brain-regions (1)
- breast cancer (1)
- burden (1)
- cAMP (1)
- cadherin (1)
- cadherins (1)
- caffeine (1)
- caffeine-induced anxiety (1)
- cancer (1)
- candidate genes (1)
- capacity (1)
- capecitabine (1)
- cardiac sympathetic nerve system (1)
- cardiology (1)
- cardiorespiratory centre (1)
- cardiovascular arousal (1)
- case fatality rates (1)
- cataphasia (1)
- catechol-O-methyltransferase (1)
- cell culture (1)
- cell membranes (1)
- cell proliferation (1)
- cells (1)
- ceramides (1)
- cerebellar ataxia (1)
- cerebellar atrophy (1)
- cerebral artery occlusion (1)
- cerebrospina (1)
- character items (1)
- child development (1)
- child memory (1)
- childhood maltreatment (1)
- cholinergic neurons (1)
- chromosome 12 (1)
- chronic distress (1)
- chronic hemodialysis (1)
- chronic stress (1)
- chronical stress (1)
- chronischer Stress (1)
- classical conditioning (1)
- classification (1)
- clinical diagnosis (1)
- clinical practice guideline (1)
- clinical trial (1)
- coagulation (1)
- coexpression (1)
- cognitive bias (1)
- cognitive deficits (1)
- cognitive dysfunction (1)
- cognitive neuropsychology in dementia (1)
- cognitive-behavioral therapy (1)
- cognitive-behavioural psychotherapy (1)
- cohort studies (1)
- community sample (1)
- comparative anatomy (1)
- complementary alternative medicine (1)
- complex interventions (1)
- comprehensive psychosomatic assessment (1)
- computer-assisted instruction (1)
- concentration (1)
- conditioning (1)
- conduct disorder (1)
- conflict detection (1)
- conflict processing (1)
- congenital heart-deffects (1)
- contextual fear conditioning (1)
- continuous performance test (1)
- control strain (1)
- coping style (1)
- coping with challenge (1)
- copy number variants (1)
- copy number variation (1)
- copy-number variation (1)
- coronavirus (1)
- corpus striatum (1)
- cortex (1)
- corticotropin releasing factor (1)
- cortisol (1)
- course (1)
- cross-sectional analysis (1)
- cross-sectional studies (1)
- cross-sectional study (1)
- crystal structure (1)
- cue-incuded craving (1)
- cue-induced craving (1)
- cytoarchitectonic maps (1)
- cytoarchitectonics (1)
- cytome biomarkers (1)
- damage (1)
- data mining (1)
- de-novo methylation (1)
- deaths (1)
- decision making (1)
- decision making process (1)
- defensive reactivity (1)
- defensive system reactivity (1)
- deficient mice (1)
- deficit (1)
- deficit hyperactivity disorder (1)
- dehydrogenases (1)
- delay (1)
- deletion (1)
- delinquency (1)
- dementia with Lewy bodies (1)
- dental phobia (1)
- depressive Störung (1)
- depressive Symptome (1)
- depressive episode (1)
- depressive symptoms (1)
- detoxification (1)
- development (1)
- developmental delay (1)
- dexamethasone (1)
- diagnosis (1)
- diagnostic medicine (1)
- dictator game (1)
- diet (1)
- differentiation (1)
- digital phenotyping (1)
- dimensions (1)
- disability (1)
- discrimination training (1)
- disease modelling (1)
- disease-modifying therapies (1)
- distraction (1)
- diuretic (1)
- dlPFC (1)
- dopamin (1)
- dopamine D2 receptor gene (1)
- dopamine melanin (1)
- dopaminergics (1)
- dorsal raphe nucleus (1)
- dorsolateral (1)
- dorsolateraler Präfrontalkortex (1)
- dorsolateraler präfrontaler Cortex (1)
- dorsolateraler präfrontaler Kortex (1)
- dot-probe (1)
- drift-diffusion model (1)
- drift-diffusion modeling (1)
- drug development (1)
- drug metabolism (1)
- drug monitoring (1)
- drug-addiction (1)
- drug-drug interaction (1)
- dual guidance (1)
- duplication (1)
- dysbindin (1)
- e-learning (1)
- eNOS (1)
- early detection (1)
- early diagnosis (1)
- early intervention (1)
- early-onset predictors (1)
- ecological momentary assessment (1)
- ectodomain cleavage (1)
- egoism (1)
- elderly (1)
- electrode recording (1)
- electroeneephalography (1)
- electron tomography (1)
- embodiment (1)
- embryos (1)
- emotional (1)
- emotional Stroop-test (1)
- emotional behavior (1)
- emotional experience (1)
- emotional influence (1)
- emotional information (1)
- emotional interference (1)
- emotional processing (1)
- emotionale Interferenz (1)
- emotionale Verarbeitung (1)
- emotionaler Stroop-Test (1)
- emotions (1)
- encephalitis lethargica (1)
- endocannabinoids (1)
- endogenous psychoses (1)
- energy expenditure (1)
- energy metabolism (1)
- entorhinal cortex (1)
- environment (1)
- enzymatic synthesis (1)
- epigenetics in the nervous system (1)
- epigenomics (1)
- error monitoring (1)
- error positivity (1)
- error processing (1)
- error-positivity (Pe) (1)
- error-related negativity (ERN) (1)
- escitalopram (1)
- estrogen receptor gene polymorphism (1)
- event-related fMRI (1)
- event-related potentials (ERP) (1)
- executive function training (1)
- exekutive Funktion (1)
- exekutive Funktionen (1)
- experimentelle Denkprüfung (1)
- exposition training (1)
- exposure therapy (1)
- exposure treatment (1)
- eyes (1)
- fMRT (1)
- facial affect (1)
- facial expression (1)
- facticious disorder (1)
- factor expression (1)
- famiIiaI ·sporadic concept (1)
- familial-sporadic concept (1)
- families (1)
- family (1)
- family caregivers (1)
- family-based association study (1)
- fatigue (1)
- fear expression (1)
- fear learning (1)
- fear memory consolidation (1)
- fear-relevant training (1)
- febrile seizures (1)
- feedback (1)
- female (1)
- ferroptosis (1)
- fetal preconditioning (1)
- fibromyalgia syndrome (1)
- fluid (1)
- fmri activity (1)
- follow-up (1)
- formal thought disorder (1)
- formale Denkstörung (1)
- freezing (1)
- frontal cortex (1)
- frontotemporal lobar degeneration (1)
- fumarate (1)
- functional resting-state connectivity (1)
- funktionelle Magnetresonanztomographie (1)
- funktionelle Nah-Infrarot Spektroskopie (1)
- funktionelle Nahinfrarotspektroskopie (1)
- funktionelle Nahinfrarotspektroskopie (fNIRS) (1)
- funktionelle Resting-State Konnektivität (1)
- fusiform gyrus (1)
- gender (1)
- gender differences (1)
- gene analysis (1)
- gene environment (1)
- gene environment interaction (1)
- gene polmorphism (1)
- gene × gene interaction (1)
- gene-by-environment interaction (1)
- gene-environment interaction (1)
- geneexpression (1)
- genetic interaction (1)
- genetic loci (1)
- genetic phenotypes (1)
- genetic risk factor (1)
- genetic variants (1)
- genetic variation (1)
- genetics memory (1)
- genome-wide (1)
- genomic organization (1)
- genomic response (1)
- genomische Bildgebung (1)
- genotype (1)
- genotype-phenotype patterns (1)
- glia (1)
- glucocorticoids (1)
- glucose (1)
- glucose tolerance (1)
- glutamate receptor (1)
- glycine (1)
- glycine receptor (1)
- glycine receptor beta subunit (1)
- glycogen synthase kinase-3β (1)
- granule cells (1)
- granules (1)
- growth factor (1)
- hand (1)
- haplotypanalysis (1)
- haplotype (1)
- haplotypeanalysis (1)
- haplotypes (1)
- head (1)
- heart failure (1)
- heat shock protein Hsc-70 (1)
- heavy user (1)
- hepcidin (1)
- heritability (1)
- heterosis (1)
- heterozygote (1)
- hierarchical drift-diffusion modeling (1)
- high-pressure freezing (1)
- hippocampal formation (1)
- hippocampal mossy fiber bouton (1)
- hippocampal neurogenesis (1)
- hippocampal volume (1)
- histamine (1)
- hospital (1)
- hospitalisation (1)
- human behaviour (1)
- human brain (1)
- human induced pluripotent stem cell (hiPSC) (1)
- human orbitofrontal cortex (1)
- hyperactivity (1)
- hypofrontality (1)
- hyponatremia (1)
- hypothalamic gene expression (1)
- iPSC (1)
- iPSCs (1)
- iTBS (1)
- iiron transporter (1)
- imaging genetics (1)
- imaging mass spectrometry (1)
- imipramine (1)
- immediate-early gene (1)
- immunology (1)
- impact (1)
- impairments (1)
- impulse control disorders (1)
- in vivo (1)
- incentives (1)
- incidence (1)
- indans (1)
- individual differences (1)
- individual quality of life (1)
- inferior frontal gyrus (1)
- inferior parietal lobule (1)
- inflammatory cytokines (1)
- inflammatory diseases (1)
- informal caregiving (1)
- information processing (1)
- inhibition (1)
- insulin resistance (1)
- insulin-like growth factor 1 receptor (1)
- intelligibility (1)
- interleukin 6 (1)
- intermediate phenotype approach (1)
- interstitial duplications (1)
- intervention study (1)
- iron in parkinsonism (1)
- iron model (1)
- iron pathology (1)
- ischemic brain injury (1)
- ischemic stroke (1)
- joint action (1)
- joint-action (1)
- judgement bias (1)
- kaliumchlorid cotransporter (1)
- kindliche Traumatisierung (1)
- klinische Verlaufsparameter (1)
- knock-out mice (1)
- knockout-mice (1)
- kognitive Leistungen (1)
- kombinierte Untersuchung (1)
- laboratory and online studies (1)
- laboratory environment (1)
- lacking (1)
- learning and memory (1)
- learning curves (1)
- learning strategies (1)
- length of stay (1)
- lethai catatonia (1)
- levodopa (1)
- life (1)
- life stress (1)
- linkage (1)
- linkage analysis (1)
- liraglutide (1)
- living kidney donation (1)
- localization microscopy (1)
- loci (1)
- locomotor activity (1)
- loneliness (1)
- longitudinal magnetic resonance imaging (1)
- mIBG (1)
- machine learning (1)
- magnetic-resonance-spectroscopy (1)
- major depressive disorder (MDD) (1)
- mammalian development (1)
- management (1)
- manisch-depressive Störung (1)
- mapping susceptibility genes (1)
- massagetherapy (1)
- massively multiplayer online role playing games (1)
- maternal (1)
- maternal infection (1)
- maternal separation (1)
- matrix metalloproteinase (1)
- maturation (1)
- mechanismofaction (1)
- mechanisms (1)
- medial prefrontal cortex (mPFC) (1)
- medial temporal lobe (1)
- median and dorsal raphe (1)
- medical Education (1)
- medical education (1)
- medicine (1)
- megalencephalic leucoencephalopathy (1)
- membrane potential (1)
- membrane proteins (1)
- memory consolidation and extinction (1)
- memory deficits (1)
- memory formation (1)
- mental arithmetic (1)
- mental illness (1)
- messenger RNA (1)
- metaanalysis (1)
- metagenomics (1)
- methylation (1)
- methylphenidate (1)
- miRNS (1)
- microRNA (1)
- microarray (1)
- microarrays (1)
- microcephalin 1 (1)
- microdeletion (1)
- micronucleus test (1)
- midbrain (1)
- middle aged (1)
- migration background (1)
- mind-body intervention (1)
- mismatch (1)
- mismatch negativity (MMN) (1)
- mitochondria (1)
- mitochondrial pathology (1)
- mitochondrial translation (1)
- mitochondrial transport (1)
- mobile crowdsensing (1)
- mobile health (1)
- moclobemide (1)
- modifizierter Dexamethason-Suppressions-Test (1)
- modulation (1)
- molecular genetics (1)
- monetary incentive delay task (1)
- monoamine (1)
- monoamine oxidase A (1)
- monoamine oxidase inhibitors (1)
- monoamine transporters (1)
- monopolar depressive disorders (1)
- monopolare endogene Depression (1)
- mood disorder (1)
- mood disorders (1)
- mood stabilizer (1)
- morality (1)
- morphological classification (1)
- morphologische Klassifikation (1)
- mother (1)
- mothers (1)
- motivation (1)
- motoneuron (1)
- movement disorders (1)
- mrsk2 KO mouse (1)
- multicenter (1)
- multimedia, (1)
- multiple myeloma (1)
- multiple sclerosis (1)
- multiple system atrophy (1)
- multi‑center cohort study (1)
- munchhausen by proxy (1)
- murine gene (1)
- murines Gen (1)
- musculus temporalis (1)
- mutation analysis (1)
- myocardial sympathetic innervation imaging (1)
- nNOS (1)
- nanoarchitecture (1)
- near-infrared spectroscopy (NIRS) (1)
- negative difference (Nd) (1)
- negative priming (1)
- negatives Priming (1)
- neonatal brain (1)
- neonatal hypoxia (1)
- nervour system (1)
- nervous system (1)
- neural activity (1)
- neural fear network activation (1)
- neural mechanisms (1)
- neural stem cells (1)
- neuregulin-1 (1)
- neurite outgrowth (1)
- neurobiology (1)
- neurodevelopmental disorders (1)
- neurodevelopmental disorders / genetics (1)
- neurofilament light chain (1)
- neuroinvasion (1)
- neurological disorders (1)
- neurological symptoms/disorders (1)
- neurology (1)
- neurolucida (1)
- neuromelanin granules (1)
- neuromorphology (1)
- neuromuscular junction (1)
- neuron (1)
- neuron navigator 3 (1)
- neuronal dendrites (1)
- neuronal differentiation (1)
- neuronal dysfunction (1)
- neuronal plasticity (1)
- neuronale NO-Synthase (1)
- neuronale NOS (1)
- neurons (1)
- neuropathic pain (1)
- neuropeptide S receptor gene (1)
- neuroplasticity (1)
- neuropsychiatry (1)
- neurorehabilitation (1)
- neuroscience (1)
- neurothrophic factor (1)
- neurotransmitter (1)
- neurotrophic factor (1)
- neurotrophic factor gene (1)
- neurotrophins (1)
- nicht-invasive Vagusnervstimulation (1)
- niederfrequente Oszillationen (1)
- nitric oxide (1)
- nitricoxidesynthase (1)
- no-suicide-contract (1)
- non-steroidal anti-inflammatory drug (1)
- nortriptyline (1)
- nucleus (1)
- nucleus accumbens (1)
- nurses (1)
- object and spatial visual working memory (1)
- objective structured clinical examination (1)
- observer agreement (1)
- obstetric complications (1)
- occupancy (1)
- of-the-literature (1)
- old age depression (1)
- older employees (1)
- onset (1)
- optic ataxia (1)
- oral anticancer drugs (1)
- organische affektive Störungen (1)
- oscillating biomagnetic fields (1)
- oxidativer Stress (1)
- oxygen consumption (1)
- pair bonding (1)
- panx1 (1)
- panx2 (1)
- panx3 (1)
- parathyroid hormone 1 receptor (1)
- parent training (1)
- parental origin (1)
- parietal lobe (1)
- parkinson’s disease (1)
- paternal (1)
- patient-doctor-relationship (1)
- patients (1)
- pediatrics (1)
- people (1)
- perception (1)
- periodische Katatonie (1)
- peripartale psychische Erkrankungen (1)
- peripheral-blood lymphocytes (1)
- perniziöse Katatonie (1)
- persistence (1)
- persistent ADHD (1)
- personality disorders (1)
- personality traits (1)
- personalized medicine (1)
- perspectives (1)
- pharmacogenetics (1)
- pharmacokinetic (1)
- pharmacology (1)
- phasic threat responding (1)
- phenelzine (1)
- phobia (1)
- phosphorylated tau protein (1)
- physical health (1)
- physiology (1)
- physiotherapy (1)
- pigment (1)
- plasma levels (1)
- polymophismus (1)
- population (1)
- population-based studies (1)
- positive affect (1)
- positive interneurons (1)
- positron-emission-tomography (1)
- post error slowing (1)
- postencephalitic parkinsonism (1)
- posterior cortical atrophy (1)
- posterior parietal cortex (1)
- posteroinferior occipitotemporal gyrus (1)
- postmortem (1)
- postmortem studies (1)
- postnatal depression (1)
- posttraumatic-stress-disorder (1)
- potassium chlorid co-transporter (1)
- precision medicine (1)
- predict (1)
- predictors (1)
- prefrontal (1)
- prefrontal Cortex (1)
- prefrontal oxygenation (1)
- pregnancy anxiety (1)
- prepulse inhibition (1)
- presynaptic (1)
- presynaptic homeostasis (1)
- prevalence (1)
- prevention (1)
- prevention test anxiety (1)
- preventive strategies (1)
- primary care (1)
- primary progressive aphasia (1)
- primary response genes (1)
- primates (1)
- process evaluation (1)
- processing bias (1)
- processing speed (1)
- proliferation (1)
- promoter (1)
- promoter region (1)
- prophylactic lithium (1)
- prosociality (1)
- protein (1)
- protein aggregation (1)
- protein kinase (1)
- präfrontal (1)
- präfrontale (1)
- präfrontale Oxygenierung (1)
- pränataler Stress (1)
- psychiatric psychotherapeutic care (1)
- psychiatric-hospitalization (1)
- psychiatrisch psychotherapeutische Versorgung (1)
- psycho-geriatrics (1)
- psychogeriatrics (1)
- psychological distress (1)
- psychological stress (1)
- psychooncology (1)
- psychopharmacotherapy (1)
- psychosocial workplace risk assessment (1)
- psychosozialer Stress (1)
- psychotic experiences (1)
- psychotropic medication (1)
- psychotropic medications (1)
- punishment (1)
- qtc (1)
- qualitative Studie (1)
- qualitative approaches (1)
- qualitative study (1)
- quality assurance (1)
- quality of live (1)
- quantitative anatomy (1)
- rTMS (1)
- randomized-controlled trial (1)
- ranskranielle magnetische Stimulation (1)
- rare diseases (1)
- rare mendelian disorders (1)
- rasagiline (1)
- rat brain (1)
- rating scale (1)
- reactivity (1)
- real-life interaction (1)
- realist evaluation (1)
- receptor (1)
- receptor gene polymorphism (1)
- receptors (1)
- reciprocity (1)
- recognition memory (1)
- reconsolidation (1)
- reconstruction (1)
- recurrent Tako-Tsubo cardiomyopathy (1)
- regenerative research (1)
- reinforcement learning theory (1)
- religiosity (1)
- remitted/acute phase (1)
- renal function (1)
- repair (1)
- repulsive guidance molecule A (1)
- research errors (1)
- resilience (1)
- resting-state fMRI (1)
- reward (1)
- reward deficiency syndrome (1)
- right inferior frontalgyrus (1)
- risk factor (1)
- risk genes (1)
- risperidone (1)
- rodent model (1)
- rule discovery (1)
- safety (1)
- safety behavior (1)
- sample size calculation (1)
- schizophrenic patients (1)
- schizophrenie (1)
- sections (1)
- selegiline (1)
- self-employed (1)
- sequence variations (1)
- serotonerge Aktivität (1)
- serotonerge Gene (1)
- serotonergic activity (1)
- serotonergic system (1)
- serotonin receptor (1)
- serotonin receptors (1)
- serotonin transporter deficient mice (1)
- serotonin(1A) receptor (1)
- serotonin-specific neurons (1)
- serotonin-transporter (1)
- sex (1)
- short-term methylphenidate brain (1)
- short-term-memory (1)
- sialic acid (1)
- sialyltransferase (1)
- signal transduction pathway (1)
- simulation (1)
- single subject (1)
- skin conductance (1)
- skin conduction response (1)
- small business (1)
- smoking cessation (1)
- social anxiety (1)
- social avoidance (1)
- social capital (1)
- social cognitive (1)
- social distancing (1)
- social experience (1)
- social isolation (1)
- social motives (1)
- social neuroscience (1)
- somatische Befunde (1)
- spastic (1)
- spatial memory (1)
- specific phobia (1)
- spectrum disorder (1)
- spectrum disorders (1)
- spezifische Phobie (1)
- sphingolipids (1)
- spontaneously hypertensive rat (1)
- spontaneously hypertensive rats (1)
- sporadic Parkinson's disease (1)
- startle reaction (1)
- states (1)
- stem cells (1)
- stereology (1)
- stimulation (TMS) (1)
- stop signal (1)
- strategies (1)
- stress granules (1)
- stressful life events (1)
- striatum (1)
- stroop interference (1)
- subphenotypes (1)
- subsctraction (1)
- subsequent memory (1)
- suicide (1)
- suicide attempt (1)
- supervisors (1)
- surrogate endpoints (1)
- survey (1)
- susceptibility (1)
- susceptibility genes (1)
- sustained threat responding (1)
- swim test (1)
- symptoms (1)
- synapse (1)
- synapse formation (1)
- synaptic plasticity (1)
- synaptic transmission (1)
- synaptic ultrastructure (1)
- synaptosomal-associated protein SNAP-25 (1)
- synaptosomal-assoziiertes Protein (1)
- synaptosomes (1)
- systematic paraphrenia (1)
- systems (1)
- systems biology (1)
- tVNS (1)
- tandem mass spectrometry (1)
- targeted bisulfite sequencing (1)
- task complexity (1)
- task difficulty (1)
- tauopathy (1)
- tdcs (1)
- teaching hospital (1)
- telomere length (1)
- temporal lobe epilepsy (1)
- temporo-parietal junction (1)
- test anxiety (1)
- thalamus (1)
- theranostic markers (1)
- therapy (1)
- theta burst stimulation (1)
- threat-related stimuli (1)
- tinnitus (1)
- tolerability (1)
- tolerance (1)
- topographic analysis (1)
- topographische EEG-Analyse (1)
- trail making test (1)
- transcranial Direct Current Stimulation (tDCS) (1)
- transcranial magnetic (1)
- transcranial magnetic stimulation (1)
- transcranial magnetic stimulation (TMS) (1)
- transcutaneous vagusnervstimulation (1)
- transient global ischemia (1)
- transkranielle Gleichstomstimulation (1)
- transkranielle Gleichstromstimulation (tDCS) (1)
- transkutane Vagusnervstimulation (1)
- transmission (1)
- transporter gene SLC2A3 (1)
- tranylcypromine (1)
- treatment (1)
- treatment guidelines (1)
- treatment response (1)
- triplet repeats (1)
- tryptophan hydroxylase 2 (1)
- tryptophan hydroxylase-2 (1)
- ubiquitination (1)
- ultra-high risk (1)
- ultrasound imaging (1)
- understaffed (1)
- unerwünschte Arzneimittelwirkungen (1)
- unsystematic paraphrenia (1)
- unsystematische Paraphrenie (1)
- use (1)
- vagus somatosensory evoked potentials (1)
- vagus-evoked potentials (1)
- valence framing (1)
- validation (1)
- validity (1)
- vbm (1)
- ventromedial prefrontal cortex (1)
- verbal fluency (1)
- verbal fluency tasc (1)
- verbal fluency task (1)
- verbal fluency test (1)
- verbal n-back (1)
- verursachende Person (1)
- vesicular monoamine transporter (1)
- vesikulärer Monoamintransporter (1)
- victims (1)
- video-game (1)
- violence (1)
- virtual patients (1)
- viruses (1)
- virus–iron interaction (1)
- visuell-bildliches Arbeitsgedächtnis (1)
- visuell-räumliches Arbeitsgedächtnis (1)
- vitamin D deficiency (1)
- vitamin d (1)
- volumetric MRI (1)
- von Economo (1)
- voxel-based morphometry (1)
- wahrnehmen (1)
- weight (1)
- withdrawal (1)
- work-related stress (1)
- world of warcraft (1)
- yoga (1)
- younger employees (1)
- Ältere Rehabilitanden (1)
- Östrogenrezeptor-Polymorphismen (1)
- ɑ-Synuclein and iron (1)
Institute
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (469) (remove)
Sonstige beteiligte Institutionen
- Clinical Trial Center (CTC) / Zentrale für Klinische Studien Würzburg (ZKSW) (2)
- Department of Nuclear Medicine, Kanazawa University (1)
- Institut für Biopsychologie, Universität Dresden (1)
- Institut für Neurowissenschaften der Universität Mailand (1)
- Interdisziplinäres Zentrum für Klinische Forschung (IZKF) Würzburg (1)
- Johns Hopkins School of Medicine, Baltimore, MD, U.S. (1)
- Johns Hopkins University School of Medicine (1)
- Maastricht University, Department of Psychiatry and Neuropsychology (1)
- Translationale soziale Neurowissenschaften (1)
ResearcherID
- N-8985-2015 (1)
Die ängstliche Depression stellt einen Subtypus der Depression dar, der noch nicht ausreichend erforscht ist und somit eine Herausforderung im klinischen Alltag darstellt. Laut der bisherigen Literatur sind genetische Unterschiede sowie Kindheitstraumatisierungen an der Pathophysiologie von Depressionen beteiligt und mitverantwortlich für die Ausprägung des Subtypus ängstliche Depression.
In dieser Untersuchung wurde erforscht, ob es unterschiedliche Genexpressionslevel des Gens NR3C1 zwischen ängstlich-depressiven und nicht-ängstlich-depressiven Personen gibt. Zusätzlich wurde geprüft, ob Kindheitstraumatisierungen einen weiteren Einfluss auf die Genexpression der beiden Subtypen der Depression haben.
Es zeigte sich, dass ängstlich-depressive Personen in Woche 1 bis 4 höhere HAM-D-Summenwerte erzielten, mit zusätzlichen Kindheitstraumatisierungen wurden die höchsten HAM-D-Werte festgestellt. Diese Gruppe hatte gehäuft Kindheitstraumata im Fragebogen angegeben, die Traumata Emotionale Misshandlung und Körperliche Vernachlässigung kamen signifikant häufiger vor.
Anhand dieser durchgeführten Studie konnten zusammengefasst werden, dass sich die Genexpressionslevel von NR3C1 zwischen den beiden Subtypen als unterschiedlich erwies. Zusätzlich scheinen die beiden Kindheitstraumata Emotionale Misshandlung und Körperliche Vernachlässigung einen weiteren Einfluss auf die Genexpression von NR3C1 zu haben.
Die unterschiedliche Genexpression von NR3C1 deutet auf verschiedene Funktionsweisen des GR zwischen den Subtypen hin. Dies könnte für die Verlaufsbeurteilung und Therapieansätze der Erkrankung von Bedeutung sein. Die häufiger vorkommenden Kindheitstraumatisierungen bei ängstlich-depressiven Personen können als ein pathophysiologischer Baustein für die Entstehung der ängstlichen Depression gesehen werden. Daher ist es umso wichtiger, das Überprüfen von erlebten Kindheitstraumata bei initialer Befragung in den klinischen Alltag mitaufzunehmen. Da auch der Depressionsschweregrad durch Kindheitstraumatisierungen in dieser Studie zunahm, ergeben sich daraus mögliche Konsequenzen für die therapeutische Planung.
Schwangerschaft und Stillzeit gehen mit erheblichen metabolischen Veränderungen des mütterlichen Organismus einher. Bis dato ist über die Pharmakokinetik von Psychopharmaka in dieser Zeit wenig bekannt. In unserer naturalistischen Beobachtungsstudie untersuchten wir 61 Frauen hinsichtlich der Dynamik psychotroper Medikamente innerhalb der Schwangerschaft und Stillzeit im Serum und teils in der Muttermilch. Zudem erhoben wir Eckdaten der Entwicklung der exponierten Kinder innerhalb des ersten Lebensjahres.
Bis auf Citalopram stellten wir bei allen analysierten Medikamenten Spiegelabfälle in der Schwangerschaft fest: vom ersten zum zweiten Trimenon fielen die Spiegel bei Escitalopram, Sertralin, Duloxetin, Amitriptylin, Clomipramin und Quetiapin. Während wir in der Spätschwangerschaft bei Escitalopram, Venlafaxin, Clomipramin, Mirtazapin, Aripiprazol und Quetiapin eine weitere Reduktion der Serumkonzentrationen protokollierten, blieben die Spiegel von Amitriptylin stabil, die Sertralin-Spiegel erholten sich sogar partiell. Citalopram zeigte keine Änderung der Serumspiegel. Direkt postpartal kam es bei allen Medikamenten zu einem Spiegelanstieg. Im postpartalen Verlauf zeigten die einzelnen Medikamente widersprüchliche Dynamiken. Hohe Penetrationsraten in die Muttermilch wiesen Escitalopram und Venlafaxin auf; Duloxetin, Clomipramin und Quetiapin gingen kaum bzw. nicht in die Muttermilch über. Wir fanden keine signifikanten Unterschiede zwischen in utero nicht exponierten zu exponierten Kindern bezüglich Geburtsparametern wie Schwangerschaftswoche, Körpermaße oder APGAR-Wert. Während die nicht exponierten Kinder vermehrt unter leichten Auffälligkeiten direkt postpartal litten, wiesen die exponierten Neugeborenen mehr mittelschwere Auffälligkeiten auf. Hinsichtlich der Entwicklung innerhalb des ersten Lebensjahres (gemessen an groben Entwicklungsmeilensteinen) ergaben sich keine signifikanten Unterschiede.
Im klinischen Alltag trägt das Therapeutische Drug Monitoring als indirekte Methode zur Kontrolle aller an der Metabolisierung beteiligten Faktoren enorm zur Steigerung der Sicherheit und Effektivität der individuellen Pharmakotherapie bei. Die pharmakokinetische Dynamik fällt bei manchen Medikamenten jedoch interindividuell sehr unterschiedlich aus (insbesondere bei Sertralin); hier stellt eine initiale Genotypisierung der Cytochrom-P450-Enzyme ein großes Potential dar, um bereits zu Beginn einer Schwangerschaft über die voraussichtliche pharmakokinetische Dynamik im Bilde zu sein und möglicher Unter- bzw. Überdosierung mit potentiell fruchtschädigender Wirkung vorbeugen zu können.
Auswirkungen der Genpolymorphismen ASIC1, BDNF und NPSR1 auf die Antizipationsphase aversiver Reize
(2024)
In dieser Arbeit wurden einerseits die Antizipationsphasen von aversiven gegenüber neutralen Reizen anhand von Messungen der Hautleitfähigkeit und der Startle-Reaktion untersucht. Andererseits wurde die Hautleitfähigkeit auch während der Präsentation aversiver und neutraler Reize mit dem Ziel gemessen, signifikante Unterschiede festzustellen. Insbesondere wurden die Auswirkungen der Allele der Gene ASIC1 und der Interaktion der Genallele BDNF und NPSR1 betrachtet.
Ziel der vorliegenden Arbeit war es, den Einfluss der Risikogene auf die physiologische Angstreaktion und die subjektive Angstwahrnehmung zu untersuchen. Hierzu wurden den genotypisierten Probanden aversive und neutrale Videos präsentiert. Vor jedem Video erfolgte die Ankündigung, ob es sich um ein neutrales oder aversives Video handelt, wodurch bei Letzterem im Allgemeinen antizipatorische Angst – Erwartungsangst – hervorgerufen wird.
Im Vergleich der Antizipationsphase vor Darbietung aversiver Videos mit der Antizipationsphase vor neutralen Videos konnte eine erhöhte Startle-Amplitude gemessen werden. Jedoch konnte weder anhand der Veränderung der Hautleitfähigkeit noch anhand der Startle-Amplitude ein signifikanter Unterschied bei Trägern und Nicht- Trägern der Risikogenallelen in der Antizipationsphase festgestellt werden. Während der Präsentation der Videos konnte für die aversiven Videos im Vergleich zu den neutralen eine erhöhte Hautleitfähigkeit gemessen werden. Ebenfalls konnte bei der Darbietung von aversiven Videos bei den Trägern der Genallel-Interaktion NPSR1 AT/TT * BDNF GG und den Trägern des Risikogenallels ASIC1TT eine erhöhte Hautleitfähigkeit gemessen werden. So konnte mit den Ergebnissen dieser Arbeit belegt werden, dass Antizipationsangst auslösbar und anhand der Startle-Amplitude messbar ist.
Um Antizipationsangst festzustellen oder diese bei Risikogenallel-Träger zu untersuchen, waren die Ergebnisse bezüglich der Hautleitfähigkeit jedoch weniger aussagekräftig als erwartet.
Allgemein konnte die Interaktion NPSR1 AT/TT * BDNF GG und ASIC1 TT als Risikogenallele bezüglich einer verstärken Reaktion auf aversive Reize bestätigt werden. Weitere Studien sind notwendig, um die genetische Komponente von Angst und damit auch von Angsterkrankungen näher zu beleuchten, damit zukünftige Diagnostik- und Therapieansätze präzise entwickelt werden können.
Emotional-associative learning processes such as fear conditioning and extinction are highly relevant to not only the development and maintenance of anxiety disorders (ADs), but also to their treatment. Extinction, as the laboratory analogue to behavioral exposure, is assumed a core process underlying the treatment of ADs. Although exposure-based treatments are highly effective for the average patient suffering from an AD, there remains a gap in treatment efficacy with over one third of patients failing to achieve clinically significant symptom relief. There is ergo a pressing need for intensified research regarding the underlying neural mechanisms of aberrant emotional-associative learning processes and the neurobiological moderators of treatment (non-)response in ADs.
The current thesis focuses on different applications of the fundamental principles of fear conditioning and extinction by using two example cases of ADs from two different multicenter trials. First, we targeted alterations in fear acquisition, extinction, and its recall as a function of psychopathology in panic disorder (PD) patients compared to healthy subjects using fMRI. Second, exposure-based therapy and pre-treatment patient characteristics exerting a moderating influence on this essential learning process later on (i.e. treatment outcome) were examined using multimodal functional and structural neuroimaging in spider phobia.
We observed aberrations in emotional-associative learning processes in PD patients compared to healthy subjects indicated by an accelerated fear acquisition and an attenuated extinction recall. Furthermore, pre-treatment differences related to defensive, regulatory, attentional, and perceptual processes may exert a moderating influence on treatment outcome to behavioral exposure in spider phobia. Although the current results need further replication, on an integrative meta level, results point to a hyperactive defensive network system and deficient emotion regulation processes (including extinction processes) and top-down control in ADs. This speaks in favor of transdiagnostic deficits in important functional domains in ADs.
Deficits in transdiagnostic domains such as emotion regulation processes could be targeted by enhancing extinction learning or by means of promising tools like neurofeedback. The detection of pre-treatment clinical response moderators, for instance via machine learning frameworks, may help in supporting clinical decision making on individually tailored treatment approaches or, respectively, to avoid ineffective treatment and its related financial costs. In the long run, the identification of neurobiological markers which are capable of detecting non-responders a priori represents an ultimate goal.
Empathy, the act of sharing another person’s affective state, is a ubiquitous driver for helping others and feeling close to them. These experiences are integral parts of human behavior and society. The studies presented in this dissertation aimed to investigate the sustainability and stability of social closeness and prosocial decision-making driven by empathy and other social motives. In this vein, four studies were conducted in which behavioral and neural indicators of empathy sustainability were identified using model-based functional magnetic resonance imaging (fMRI).
Applying reinforcement learning, drift-diffusion modelling (DDM), and fMRI, the first two studies were designed to investigate the formation and sustainability of empathy-related social closeness (study 1) and examined how sustainably empathy led to prosocial behavior (study 2). Using DDM and fMRI, the last two studies investigated how empathy combined with reciprocity, the social norm to return a favor, on the one hand and empathy combined with the motive of outcome maximization on the other hand altered the behavioral and neural social decision process.
The results showed that empathy-related social closeness and prosocial decision tendencies persisted even if empathy was rarely reinforced. The sustainability of these empathy effects was related to recalibration of the empathy-related social closeness learning signal (study 1) and the maintenance of a prosocial decision bias (study 2). The findings of study 3 showed that empathy boosted the processing of reciprocity-based social decisions, but not vice versa. Study 4 revealed that empathy-related decisions were modulated by the motive of outcome maximization, depending on individual differences in state empathy.
Together, the studies strongly support the concept of empathy as a sustainable driver of social closeness and prosocial behavior.
Fear and anxiety disorders – interaction of AVP and OXT brain systems with the serotonergic system
(2023)
Anxiety disorders pose a great burden onto society and economy and can have devastating consequences for affected individuals. Treatment options are still limited to psychopharmacotherapy originally developed for the treatment of depression and behavioral therapy. A combination of genetic traits together with aversive events is most likely the cause of these diseases. Gene x environment studies are trying to find a link between genetic traits and specific negative circumstances. In a first study, we focused on social anxiety disorder (SAD), which is the second most-common anxiety disorder after specific phobias. We used a social fear conditioning (SFC) paradigm, which is able to mimic the disease in a mouse model. We wanted to investigate protein levels, as well as mRNA expression of immediate early genes (IEGs), to determine brain areas affected by the paradigm. We also included genes of the vasopressin (AVP)-, oxytocin (OXT)-, neuropeptide Y (NPY)-, and the serotonin system, to investigate the effects of SFC on neurotransmitter gene expression levels in brain regions related to social as well as fear-related behavior. AVP and OXT regulate a lot of different social and anxiety-related behaviors, both positive and negative. Finding a link between different neurotransmitter systems in the development of anxiety disorders could help to identify potential targets for new treatment approaches, which are desperately needed, because the rate of patients not responding to available treatment is very high.
We were able to show altered gene expression of the IEGs cFos and Fosl2, as well as a change in number and density of cFOS-positive cells in the dorsal hippocampus, indicating an influence of SFC on neuronal activity. Our results reveal a possible involvement of anterior dentate gyrus (DG), as well as cornu ammonis area 1 (CA1) and CA3 in the dorsal hippocampus during the expression of social fear. Contrary to our hypothesis, we were not able to see changes in neuronal activity through expression changes of IEGs in the amygdala. Significant higher IEG immunoreactivity and gene expression in the dorsal hippocampus of animals without fear conditioning (SFC-), compared to animals with fear conditioning (SFC+), indicate an involvement of different hippocampal regions in two possible scenarios. Either as elevated gene expression in SFC- animals compared to SFC+ animals or as reduction in SFC+ animals compared to SFC- animals. However, this question cannot be answered without an additional control of basal IEG-activity without social interaction. The NPY system in general and the neuropeptide y receptor type 2 in particular seem to be involved in regulating the response to social fear, mostly through the septum region. In addition to that, a possible role for the induction of social fear response could be identified in the serotonergic system and especially the serotonin receptor 2a of the PVN.
In a second study we focused on changes in the serotonergic system. A polymorphism in the human serotonin transporter (5-HTT) gene is associated with higher risks for the development of anxiety disorders. This makes the 5-HTT a widely used target to study possible causes and the development of anxiety disorders. In mice, a genetically induced knockout of the 5-Htt gene is associated with increased anxiety-like behavior. High amounts of stress during pregnancy, also known as prenatal stress, significantly increase the risk to develop psychiatric disorders for the unborn child. We utilized a prenatal stress paradigm in mice heterozygous for the 5-Htt gene. Some of the animals which had been subjected to prenatal stress showed noticeably “unsocial” interaction behavior towards conspecifics. Again, we were searching for links between the serotonergic system and AVP- and OXT systems. Through quantitative gene expression analysis, we were able to show that both AVP and OXT neuromodulator systems are affected through prenatal stress in female mice, but not in male mice. The 5-Htt genotype seems to be only slightly influential to AVP, OXT or any other neurotransmitter system investigated. Gene expression of AVP and OXT brain systems is highly influenced through the estrous cycle stages of female mice. Additionally, we analyzed the AVP and OXT neuropeptide levels of mice with different 5-Htt genotypes and in both sexes, in order to see whether the production of AVP and OXT is influenced by 5-Htt genotype. On neuropeptide level, we were able to identify a sex difference for vasopressin-immunoreactive (ir) cells in the PVN, with male mice harboring significantly more positive cells than female mice.
Bereits in vorausgegangenen Studien konnte nachgewiesen werden, dass das Stathmin-Gen eine entscheidende Rolle im Hinblick auf erlernte und angeborene Angstreaktionen spielt. So konnte Frau Dr. Julia Katharina Heupel in ihrer Arbeit aus dem Jahr 2013 eine Assoziation eines (TAA)n-Polymorphismus, welcher sich ca. 2 kb upstream des ersten Exons des Stathmin-Gens und ca. 4 kb upstream des Translationsstarts befindet, mit Cluster-C-Persönlichkeitsstörungen belegen.
Sie vermutete, dass eine Hochregulation der Expression des Stathmin-Gens ein Risikofaktor für die Entstehung von Cluster C Persönlichkeitsstörungen darstellen könnte.
Da sich der beschriebene Polymorphismus in der Promotor-Region des Stathmin-Gens befindet, ist eine allelspezifische Auswirkung auf die Genexpression vorstellbar. Um diese Vermutung zu stützen, wurde in dieser Arbeit die Auswirkung zweier Allele des STR-Polymorphismus im Bereich der Promotorregion des Stathmin-Gens im Hinblick auf die Promotoraktivität untersucht.
Hierzu wurde die zu untersuchende Sequenz zunächst mittels Polymerase-Ketten-Reaktion vervielfältigt und anschließend in einen pGL4.23.Vektor kloniert.
Im Anschluss daran erfolgte die Untersuchung der Promotoraktivität mittels eines Luciferase-Assays in der humanen Neuroblastomzelllinie SH-SY5Y.
Nach statischer Auswertung der Messreihen zeigte sich eine signifikant höhere Luciferase-Aktivität des STR-Polymorphismus (TAA)12 im Vergleich zu dem STR-Polymorphismus (TAA)13.
Hierdurch kann von einer höheren Promotoraktivität bei dem Genotyp (TAA)12 gegenüber dem Genotyp (TAA)13 ausgegangen werden.
Zusammenfassend unterstützen die Ergebnisse dieser Arbeit die These, dass es sich bei dem Stathmin-Gen um ein Suszeptibilitätsgen für die Entstehung von Cluster C Persönlichkeitsstörungen handeln könnte.
Social contact is an integral part of daily life. Its health-enhancing effects include reduced negative affective experiences of fear and anxiety, a phenomenon called social buffering. This dissertation studied different forms of social contact and their anxiety-buffering effects with diverse methodologies.
The laboratory-based first study investigated minimal social contact in the context of pain relief learning. Results showed that the observed decreased autonomic and increased subjective fear responses following pain relief learning were independent of social influence. The minimalistic and controlled social setting may have prevented social buffering. Study 2 targeted social buffering in daily life using Ecological Momentary Assessment. We repeatedly assessed individuals’ state anxiety, related cardiovascular responses, and aspects of social interactions with smartphones and portable sensors on five days. Analyses of over 1,500 social contacts revealed gender-specific effects, e.g., heart rate-reducing effects of familiarity in women, but not men. Study 3 examined anxiety, loneliness, and related social factors in the absence of social contact due to social distancing. We constructed and validated a scale measuring state and trait loneliness and isolation, and analysed its link to mental health. Results include a social buffering-like relation of lower anxiety with more trait sociability and sense of belonging.
In sum, the studies showed no fear reduction by minimal social contact, but buffering effects relating to social and personal factors in more complex social situations. Anxiety responses during daily social contacts were lower with more familiar or opposite-gender interaction partners. During limited social contact, lower anxiety related to inter-individual differences in sociability, social belonging, and loneliness. By taking research from lab to life, this dissertation underlined the diverse nature of social contact and its relevance to mental health.
Due to the global aging society and the enormous global incidence and prevalence rates that will result in the coming years, Alzheimer's Dementia (AD) represents a growing challenge for the health care system. The pathogenesis, which is unclear in parts, the chronic progression of AD, which often lasts for years, as well as insufficient diagnostic and therapeutic options complicate an adequate psychotherapeutic and medical approach to the disease. To date, AD is also considered an incurable disease.
Therefore, it is essential to gain deeper insights into the early detection or even prevention of AD. Consideration of prodromal syndromes such as Mild Cognitive Impairment (MCI) can provide significant evidence about high-risk groups for AD progression and differentiate cognitively "normal" aging individuals from those with pathological cognitive decline. Thus, for example, functional Near-Infrared Spectroscopy (fNIRS) imaging helps identify early neurodegenerative processes. In contrast, potential risk factors and predictors of later-onset clinical symptoms of MCI and AD can most often be revealed and quantified via the use of neuropsychiatric test batteries.
The present thesis consists of four studies and aimed to assess and describe the pathological cognitive decline in a sample of elderly study participants (age: ≥ 70 years; N = 604 at baseline) of the longitudinal, observational, and prospective "Vogel Study" from Würzburg, Germany, who were primarily healthy at baseline, over two measurement time points approximately 3 years apart, to differentiate between healthy and diseased study participants and to define predictors of MCI/AD and longitudinal study dropout.
Studies 1 and 2 differentiated healthy study participants from MCI patients based on the baseline hemodynamic response of the parietal cortex recorded by fNIRS during the processing of a paradigm (here: Angle Discrimination Task [ADT]) for visual-spatial processing performance. Neuronal hypoactivity was found in the MCI patients, with both healthy study participants and MCI patients showing higher superior and right hemispheric activation. MCI patients had more difficulty resolving the paradigm. Thus, no evidence of possible compensatory mechanisms was uncovered in the MCI patients.
Study 3 first defined the four latent factors declarative memory, working memory, attention, and visual-spatial processing based on structural equation model (SEM) calculations of the sample using adequate measurement (in-)variant confirmatory factor models from the baseline assessment to the first of a total of two follow-up assessments after approximately 3 years. This allowed a dimensional assessment of pathological cognitive decline versus classificatory-categorical assignment (healthy/diseased) of the sample. In addition, the superiority of the latent factor approach over a composite approach was demonstrated. Next, using a mixed-model approach, predictive analyses were calculated for the prediction of latent factors at first follow-up by baseline risk factors. The sex of study participants proved to be the best predictor of cognitive change in all the cognitive domains, with females performing better than men in the memory domains. Specifically, for declarative memory, older age predicted lower performance regardless of sex. Additional predictive evidence emerged for low serum levels of Brain-Derived Neurotrophic Factor (BDNF) on lower attention performance and higher depression symptoms on lower visual-spatial processing performance.
Study 4 further reported baseline predictors of study dropout at first follow-up. Cognitive performance, as defined in Study 3 using the four latent cognitive factors, was a predictor of study dropout for cognitive decline in the domains of declarative memory, attention, and visual-spatial processing. Conspicuous dementia screening on the Mini-Mental Status Examination (MMSE) also predicted dropout.
Overall, both the use of fNIRS imaging to detect visual-spatial processing performance in the parietal cortex during applying ADT and the dimensional perspective of the neuropsychiatric test battery in the context of prediction and dropout analyses were found to be suitable for early detection research of MCI and AD. Finally, the results will be interpreted in the overall context and implications, limitations, and perspectives will be discussed.
Even though exposure-based cognitive behavioral therapy (CBT) constitutes a first-line treatment for anxiety disorders, a substantial proportion of patients does not respond in a clinically significant manner. The identification of pre-treatment patient characteristics that are associated with treatment outcome might aid in improving response rates. Therefore, the present doctoral thesis aimed at investigating moderators of treatment outcome in anxiety disorders: first, we investigated the neural correlates of comorbidity among primary panic disorder/agoraphobia (PD/AG) and secondary social anxiety disorder (SAD) moderating treatment outcome towards exposure-based CBT. Second, pre-treatment functional resting-state connectivity signatures of treatment response in specific phobia were studied. Within the first study, we compared PD/AG patients with or without secondary SAD regarding their clinical and neurofunctional outcome towards a manualized CBT treatment focusing on PD/AG symptoms. Prior to treatment, PD/AG+SAD compared to PD/AG-SAD patients exhibited a specific neural signature within the temporal lobe, which was attenuated to the level of PD/AG-SAD patients afterwards. CBT was equally effective in both groups. Thus, comorbidity among those two anxiety disorders did not alter treatment outcome substantially. This might be due to the high overlap of shared pathophysiological features within both disorders. In the second study, we assessed pre-treatment functional resting-state connectivity within a sample of spider phobic patients that were treated with massed in virtuo exposure. We found responders already prior to treatment to be characterized by stronger inhibitory frontolimbic connectivity as well as heightened connectivity between the amygdala and regions related to the ventral visual stream. Furthermore, patients demonstrating high within-session extinction exhibited pronounced intrinsic prefrontal connectivity. Our results point to responders exhibiting a brain prepared for the mechanism of action of exposure. Taken together, results highlight the major impact of pre-treatment characteristics on treatment outcome. Both, PD/AG+SAD patients as well as responders within the SpiderVR study exhibited heightened activation or connectivity within the ventral visual pathway and the amygdala. Pronounced visual processing together with enhanced executive control and emotion regulation seem to constitute a fruitful soil for successful exposure. The results provide starting points for personalized treatment approaches in order to improve treatment success in the anxiety disorders. Future studies are needed to investigate the benefit of neuroscientifically informed CBT augmentation strategies such as repetitive transcranial magnetic stimulation.
While the healthy brain works through balanced synaptic communication between
glutamatergic and GABAergic neurons to coordinate excitation (E) and inhibition (I), disruption
of E/I balance interferes with synaptic communication, information processing, and ultimately
cognition. Multiple line of evidence indicates that E/I imbalance represents the
pathophysiological basis of a wide spectrum of mental disorders. Genetic screening
approaches have identified Cadherin-13 (CDH13). as a risk gene across neurodevelopmental
and mental disorders. CDH13 regulates several cellular and synaptic processes in brain
development and neuronal plasticity in adulthood. In addition to other functions, it is specifically
localized at inhibitory synapses of parvalbumin- and somatostatin-expressing GABAergic
neurons. In support of CDH13’s function in moderating E/I balance, electrophysiological
recordings of hippocampal slices in a CDH13-deficient mouse model revealed an increase in
basal inhibitory but not excitatory synaptic transmission. Moreover, the search for genetic
variants impacting functional expression of the CDH13 gene identified SNP (single nucleotide
polymorphism)) rs2199430 in intron 1 to be associated with differential mRNA concentrations
in human post-mortem brain across the three genotypes CDH13G/G, CDH13A/G and CDH13A/A
.
This work therefore aimed to further validate these findings in a complementary human model
by using induced pluripotent stem cells (iPSCs). The application of human iPSCs in research
has replaced the use of embryonic cells, resolving the ethical conflict of destructive usage of
human embryos. Investigating CDH13’s mode of action in inhibitory synapses was predicted
to facilitate mechanistic insight into the effects of CDH13 gene variants on E/I network activity,
which can then be targeted to reinstate balance.
Genome-wide association studies have identified rare copy number variants (CNVs) resulting
in a deletion (or duplication) of CDH13. To reduce genetic background variance, a set of
isogenic iPSC lines with a gene dose-dependent deficiency of CDH13 (CDH13-/- and CDH13+/-
) was generated by using the Clustered Regulatory Interspaced Short Palindromic
Repeats/CRISPR-associated protein 9 (CRISPR/Cas9) system. These CRISPRed iPSCs
carrying a single or two allele(s) with CDH13 inactivation facilitate investigation of CDH13
function in cellular processes, at inhibitory synapses and in neuronal network activity. In
addition, iPSCs carrying allelic SNP rs2199430 variants were used to study the effects of
common genetic variation of CDH13. These cell lines were differentiated into pure
glutamatergic and GABAergic neurons and co-cultured to generate neuronal networks allowing
its activity to be measured and correlated with electrophysiological signatures of differential
CDH13 genotypes. The work towards assessment of neuronal network activity of the iPSC
lines was subdivided into three major steps: first, generating rtTA/Ngn2 and rtTA/Ascl1-positive
iPSCs via a lentivirus-mediated approach; second, differentiating pure glutamatergic and
GABAergic neurons from the genetically transduced iPSCs and co-culturing of pure
glutamatergic and GABAergic neurons in a pre-established ratio (65:35) by direct
differentiation upon supplementation with doxycycline and forskolin on a microelectrode array
(MEA) chip; and, finally, recording of neuronal network activity of iPSC lines after 49 days in
vitro, followed by extraction and analyses of multiple MEA parameters.
x
Based on the MEA parameters, it was confirmed that complete CDH13 knockout as well as
heterozygous deficiency influence E/I balance by increasing inhibition. It was further revealed
that common SNP variation alters the signature of neuronal network activity. Specifically,
CDH13 deficiency resulted in a significant reduction in network burst duration (NBD), reduced
number of detected spikes within a network burst and reduction in network burst rate (NBR)
compared to the control (CDH13G/G). CDH13A/G and CDH13A/A showed similarities with the
CRISPRed CDH13-deficient networks by showing a significant reduction in the NBD and a
reduced number of detected spikes within a network compared to CDH13G/G. Strikingly. there
was a significant increase in the NBR of the CDH13A/G and CDH13A/A compared to CDH13G/G
networks. CDH13A/G networks exhibited significant differences in both parameters. At the
cellular level, this indicates that signalling pathways which determine the length and frequency
of network bursts differ among allelic variants of SNP rs2199430, thus confirming functional
relevance of this intronic SNP.
In summary, CDH13-deficient isogenic iPSC lines were generated using CRISPR/Cas9, iPSCs
were genetically transduced via a lentivirus approach, direct differentiation of
glutamatergic/GABAergic neurons derived from transduced iPSCs were used to establish a
scalable co-culture system, and network activity was recorded by MEA using pre-established
parameters to extract and analyze activity information. The results indicate that iPSC-derived
neuronal networks following CRISPR/Cas9-facilitated CDH13 inactivation, as well as networks
with allelic SNP variants of CDH13, moderate E/I balance, thus advancing understanding of
CDH13 function at inhibitory synapses and elucidating the effects of rare and common CDH13
gene variation.
Predictability of threat is one of the key modulators of neural activity in fear and anxiety-related threat processes and there is a considerable number of studies focusing on the exact contribution of centromedial amygdala and Bed nucleus of stria terminalis (BNST) in animals as well as in humans. In this research field, some studies already investigated the differential involvement of both areas during temporally predictable and unpredictable threat processes in humans. However, these studies showed several limitations e.g. small sample size, no predictable threat conditions, no separation of anticipation and confrontation processes, which should be addressed in future studies. Furthermore, evidence for group-based inter-individual differences of amygdala and BNST activity during predictable and unpredictable threat processes have not been studied extensively.
Several studies suggest a relevant role of the amygdala and BNST activity in phobic processes in patients with specific phobia, but no study so far has investigated the exact contribution of centromedial amygdala (CM) and BNST during temporally predictable and unpredictable threat processes in specific phobia.
This thesis consisted of three studies and aimed to evaluate the exact contribution of CM and BNST during temporally predictable and unpredictable threat anticipation and confrontation with the use of an optimized functional magnetic resonance imaging (fMRI) paradigm, which aimed to solve methodological limitations of recent studies. Study 1 used a large sample of healthy participants who were grouped based on NPSR1 genotype, and study 2 and study 3 used a sample of patients with spider phobia. In sum, the results of all three studies indicated, that BNST is more relevant for anticipation processes as compared to the CM. Contrary, during the confrontation phase the CM displays a greater relevance for threat confrontation processes.
In recent years, various studies have investigated the extent to which treatment success can be predicted in patients with anxiety disorders based on pre-treatment fMRI activity. Therefore, this was investigated for the first time in study 3 in patients with spider phobia during temporally predictable and unpredictable threat processes. Results indicated that independent of temporal predictability lower anterior cingulate cortex (ACC) activity during threat anticipation and engaged BNST during threat confrontation might be benefitting factors for successful therapy response in spider phobia.
Aggression and deficient cognitive control problems are widespread in psychiatric disorders, including major depressive disorder (MDD). These abnormalities are known to contribute significantly to the accompanying functional impairment and the global burden of disease. Progress in the development of targeted treatments of excessive aggression and accompanying symptoms has been limited, and there exists a major unmet need to develop more efficacious treatments for depressed patients. Due to the complex nature and the clinical heterogeneity of MDD and the lack of precise knowledge regarding its pathophysiology, effective management is challenging. Nonetheless, the aetiology and pathophysiology of MDD has been the subject of extensive research and there is a vast body of the latest literature that points to new mechanisms for this disorder. Here, we overview the key mechanisms, which include neuroinflammation, oxidative stress, insulin receptor signalling and abnormal myelination. We discuss the hypotheses that have been proposed to unify these processes, as many of these pathways are integrated for the neurobiology of MDD. We also describe the current translational approaches in modelling depression, including the recent advances in stress models of MDD, and emerging novel therapies, including novel approaches to management of excessive aggression, such as anti-diabetic drugs, antioxidant treatment and herbal compositions.
There is still limited knowledge about alterations of blood concentrations of psychotropic drugs during pregnancy, the transfer of psychotropic drugs into breastmilk and the effects on exposed children. We investigated changes in concentrations of psychopharmacological medication during pregnancy and lactation in serum and breastmilk at different time points in a naturalistic sample of 60 mothers and observed the development of the exposed children in the first 12 months. We found a decrease in serum concentrations from the first to the second trimester of amitriptyline, duloxetine, escitalopram, quetiapine and sertraline. Citalopram stayed rather stable during pregnancy, sertraline levels interestingly increased again from the second to the third trimester. High concentration-by-dose ratios in breastmilk were found for venlafaxine as well as lamotrigine, low for quetiapine and clomipramine. Similarly, clomipramine and quetiapine showed low milk/serum–penetration ratios. Regarding the birth outcome measures in children, we found no significant differences between in utero exposed compared to nonexposed newborns. There were no significant differences in the development in the first 12 months. Psychotropic medication in the peripartum needs a balancing of risks and benefits and a continuous therapeutic drug monitoring can be a guidance for clinicians to monitor drug alteration patterns, which are likely to occur due to physiological pregnancy-associated changes in pharmacokinetics. Accordingly, therapeutic drug monitoring can optimize a medication in pregnancy and lactation with the lowest effective dose.
Die vorliegende retrospektive Untersuchung arbeitete mit Daten von 153 Patienten der Neurogerontopsychiatrischen Tagesklinik Würzburg. Dabei wurde zum einen geprüft, ob multimorbide Patienten und niereninsuffiziente Patienten höhere dosiskorrigierte Serumkonzentrationen der Antidepressiva Escitalopram, Sertralin, Venlafaxin und Mirtazapin aufwiesen. Zum anderen erfolgte die Untersuchung, ob hohe Serumkonzentrationen der vier
genannten Antidepressiva zu einem besseren Therapieergebnis führten.
Für die Berechnungen wurden die letzten vor Entlassung erhobenen Laborparameter verwendet. Es erfolgte die Berechnung der dosiskorrigierten Serumkonzentration. 76 Patienten (49,7 %) wurden als multimorbide eingestuft.
Es zeigten sich für die dosiskorrigierte Serumkonzentration des
aktiven Metaboliten O-Desmethyl-Venlafaxin statistisch signifikant höhere
Konzentrationen bei der multimorbiden Subgruppe.
Ferner zeigte sich bei 140 Patienten eine Niereninsuffizienz (91,5 %). Für die dosiskorrigierte Konzentration von O-Desmethyl Venlafaxin, die dosiskorrigierte Summenserumkonzentration aus Venlafaxin und O-Desmethyl- Venlafaxin sowie die dosiskorrigierte Serumkonzentration von Sertralin ließen sich statistisch signifikant höhere Konzentrationen bei einer zunehmenden Einschränkung der Nierenfunktion nachweisen.
Es zeigte sich kein Einfluss der Höhe der dosiskorrigierten Serumkonzentration der
Antidepressiva auf das Therapieergebnis in der vorliegenden Arbeit.
Mit der vorliegenden Arbeit konnte gezeigt werden, dass sowohl Multimorbidität als
auch Niereninsuffizienz einen Einfluss auf die Verstoffwechselung und
auch die dosiskorrigierte Serumkonzentration der Antidepressiva Venlafaxin und
Sertralin haben. Daher ergibt sich die Schlussfolgerung, dass bei
älteren Patienten, welche von Multimorbidität oder Niereninsuffizienz betroffen sind,
eine Dosisanpassung und regelmäßige Kontrollen der Serumkonzentration im Sinne
eines Therapeutischen Drug Monitoring erfolgen sollten.
Ziel dieser Arbeit war es, den Einfluss psychosozialer Belastungsfaktoren auf den Verlauf einer Stammzelltransplantation zu untersuchen. Die primäre Fragestellung war, ob sich das Vorliegen einer posttraumatischen Belastungsstörung (PTSD) auf die Dauer der Immunrekonstitution, gemessen an der Aplasiezeit, auswirkt. Der Untersuchung liegen Daten aus der Medizinischen Klinik und Poliklinik II des Universitätsklinikums Würzburg zugrunde, die im Rahmen einer monozentrischen Querschnittsstudie erhoben wurden. An der Studie nahmen 50 Patienten mit der Diagnose eines Multiplen Myeloms teil, die am Tag ihrer ersten autologen Stammzelltransplantation befragt wurden. Anhand von Fragebögen konnten die Patienten Angaben zu ihrer individuellen psychischen Belastung machen. Für die statistische Auswertung wurden die Angaben aus dem NCCN-Distress-Thermometer und dem PCL-C ausgewertet.
Neural responses to a working memory task in acute depressed and remitted phases in bipolar patients
(2023)
(1) Cognitive impairments such as working memory (WM) deficits are amongst the most common dysfunctions characterizing bipolar disorder (BD) patients, severely contributing to functional impairment. We aimed to investigate WM performance and associated brain activation during the acute phase of BD and to observe changes in the same patients during remission. (2) Frontal brain activation was recorded using functional near-infrared spectroscopy (fNIRS) during n-back task conditions (one-back, two-back and three-back) in BD patients in their acute depressive (n = 32) and remitted (n = 15) phases as well as in healthy controls (n = 30). (3) Comparison of BD patients during their acute phase with controls showed a trend (p = 0.08) towards lower dorsolateral prefrontal cortex (dlPFC) activation. In the remitted phase, BD patients showed lower dlPFC and ventrolateral prefrontal cortex (vlPFC) activation (p = 0.02) compared to controls. No difference in dlPFC and vlPFC activation between BD patients’ phases was found. (4) Our results showed decreased working memory performance in BD patients during the working memory task in the acute phase of disease. Working memory performance improved in the remitted phase of the disease but was still particularly attenuated for the more demanding conditions.
Valence framing effects refer to inconsistent choice preferences in response to positive versus negative formulation of mathematically equivalent outcomes. Here, we manipulate valence framing in a two-alternative forced choice dictator game using gains and losses as frames to investigate the cognitive mechanisms underlying valence framing. We applied a Drift-Diffusion Model (DDM) to examine whether gain (i.e., “take” money) and loss (i.e., “give” money) frames evoke a cognitive bias as previous research did not consistently reveal framing effects using reaction times and response frequency as dependent variables. DDMs allow decomposing the decision process into separate cognitive mechanisms, whereby a cognitive bias was repeatedly associated with a shift in the starting point of the model. Conducting both a laboratory (N = 62) and an online study (N = 109), female participants allocated money between themselves and another person in a prosocial or selfish way. In each study, one group was instructed to give money (give frame), the other to take money (take frame). Consistent with previous studies, no differences were found in response times and response frequencies. However, in both studies, substantial bias towards the selfish option was found in the take frame groups, captured by the starting point of the DDM. Thus, our results suggest that valence framing induces a cognitive bias in decision processing in women, even when no behavioral differences are present.
Angsterkrankungen stellen mit einer 12-Monats-Prävalenz von 14% die häufigsten psychischen Erkrankungen in der westlichen Gesellschaft dar. Angesichts der hohen querschnittlichen wie sequentiellen Komorbidität von Angsterkrankungen, der ausgeprägten individuellen Einschränkungen sowie der hohen ökonomischen Belastung für das Gesundheitssystem ist neben therapeutischen Behandlungsansätzen die Entwicklung von kurzzeitigen, kostengünstigen und leicht zugänglichen Präventionsmaßnahmen von großer Bedeutung und steht zunehmend im Fokus des gesundheitspolitischen Interesses, um die Inzidenz von Angsterkrankungen zu reduzieren. Voraussetzung für die Entwicklung von gezielten und damit den effektivsten Präventionsmaßnahmen sind valide Risikofaktoren, die die Entstehung von Angsterkrankungen begünstigen. Ein Konstrukt, das in der Literatur als subklinisches Symptom in Form einer kognitiven Vulnerabilität für Angsterkrankungen und damit als Risikofaktor angesehen wird, ist die sogenannte Angstsensitivität (AS). AS umfasst die individuelle Tendenz, angstbezogene körperliche Symptome generell als bedrohlich einzustufen und mit aversiven Konsequenzen zu assoziieren.
Das Ziel der vorliegenden Arbeit war daher die Etablierung und Validierung eines Präventionsprogramms zur Reduktion der AS an einer nicht-klinischen Stichprobe von 100 Probanden (18-30 Jahre) mit einer erhöhten AS (Anxiety Sensitivity Index [ASI-3] ≥17) sowie die Rekrutierung von 100 alters- und geschlechtsangeglichenen Probanden mit niedriger Angstsensitivität (ASI-3 <17). In einem randomisiert-kontrollierten Studiendesign durchliefen die Probanden mit hoher AS entweder das über fünf Wochen angelegte „Kognitive Angstsensitivitätstraining“ (KAST) als erste deutschsprachige Übersetzung des Computer-basierten „Cognitive Anxiety Sensitivity Treatment“ (CAST) von Schmidt et al. (2014) oder wurden der Wartelisten-Kontrollgruppe zugeteilt. Das KAST Training bestand aus einer einmaligen Vermittlung kognitiv-behavioraler Psychoedukation zum Thema Stress und Anspannung sowie deren Auswirkungen auf den Körper und der Anleitung von zwei interozeptiven Expositionsübungen (‚Strohhalm-Atmung‘ und ‚Hyperventilation‘), die über den anschließenden Zeitraum von fünf Wochen in Form von Hausaufgaben wiederholt wurden.
Es konnte gezeigt werden, dass die Teilnehmer des KAST-Programms nach Beendigung des Trainings (T1) eine signifikant niedrigere AS-Ausprägung im Vergleich zur Wartelisten-Kontrollgruppe aufwiesen und diese Reduktion auch über den Katamnese-Zeitraum von sechs Monaten (T2) stabil blieb. Ergänzend wurde auch die Targetierbarkeit weiterer intermediärer Risikomarker wie der Trennungsangst (TA), des Index der kardialen Sensitivität sowie der Herzratenvariabilität (HRV) untersucht, die jedoch nicht durch das KAST-Training direkt verändert werden konnten. Im Vergleich der Subgruppen von Probanden mit hoher AS und gleichzeitig hoher TA (Adult Separation Anxiety Questionnaire [ASA-27] ≥22) und Probanden mit hoher AS, aber niedriger TA (ASA-27 <22) zeigte sich, dass die AS-TA-Hochrisikogruppe ebenfalls gut von der KAST-Intervention profitieren und eine signifikante Reduktion der AS erzielen konnte, indem sie sich bei T1 dem Niveau der Gruppe mit niedriger TA anglich. Zudem korrelierte die prozentuale Veränderung der Einstiegswerte der inneren Anspannung während der Strohhalm-Atmungsübung positiv mit der prozentualen Veränderung der dimensionalen TA bei T1.
Zusammenfassend weisen die Ergebnisse der vorliegenden Arbeit erstmalig auf die Wirksamkeit der deutschsprachigen Übersetzung des CAST-Programms (Schmidt et al., 2014), eines Computer-basierten, und damit leicht zu implementierenden sowie kostengünstigen Programms, in Bezug auf die Reduktion der AS sowie indirekt der TA hin und können damit zur indizierten und demnach besonders effektiven Prävention von Angsterkrankungen in Hochrisikogruppen beitragen.